Each material 8-K filed by a company listed on a US stock exchange (NYSE, Nasdaq, Cboe), read and summarized: what happened, the key numbers, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). This page lists the last 45 days; every brief stays on its company's 8-K page (4787 companies, A–Z).
Coursera's board adopted a limited-duration stockholder rights plan, effective immediately, in response to a stockholder that its recent filings show owns about 14.7% of the common stock. The plan is designed to trigger if any person or group acquires 15% or more without board approval, which would dilute that holder's stake and could deter open-market accumulation.
The board declared a dividend of one preferred share purchase right per common share, payable November 19, 2026 to holders of record on that date.
Each right allows purchase of one one-thousandth of a preferred share for $19.50, becoming exercisable only after a person or group acquires 15% or more.
The rights expire November 7, 2027, and the board may redeem them for $0.01 per right before any person becomes an acquiring person.
The Certificate of Designations was filed with the Delaware Secretary of State on November 9, 2026.
Silexion Therapeutics, a Cayman Islands company trading on Nasdaq as SLXN, announced a 1-for-24 reverse share split of its ordinary shares. Split-adjusted trading begins at market open on November 11, 2026, and the company says the split is intended to help it regain compliance with Nasdaq's minimum bid price requirement.
Every 24 ordinary shares will be automatically combined into one share, with the par value increasing from $0.135 to $3.24 per share
Split-adjusted trading begins on the Nasdaq Capital Market at market open on November 11, 2026, under the existing ticker SLXN, with the split effective after market close on November 10, 2026
No fractional shares will be issued; DTC participants entitled to fractions will receive a rounded-up whole share, and shareholders need not take action
FACT II Acquisition Corp., a Cayman Islands blank-check company, is asking shareholders to approve extending its deadline to complete an initial business combination from November 27, 2026 to November 25, 2027, at an extraordinary general meeting set for November 17, 2026. The company also disclosed that it and its sponsor intend to seek non-redemption agreements, under which investors would agree not to redeem shares in exchange for future share transfers, which could increase the cash left in the trust account; the company states no assurance that such incentives will be offered.
Shareholder meeting scheduled for November 17, 2026, at 10:00 a.m. Eastern Time; the deadline to submit shares for redemption is 5:00 p.m. Eastern Time on November 13, 2026.
Estimated redemption price was approximately $10.81 per share as of November 6, 2026, based on about $189,186,398.23 in the trust account.
Sponsor HoldCo anticipates transferring Class B ordinary shares to non-redeeming investors, with terms set in the Non-Redemption Agreements (Exhibit 10.1).
Corebridge Financial entered into a Share Repurchase Agreement with Argon Holdco LLC on November 6, 2026, to repurchase its common stock for an aggregate purchase price of approximately $110 million. The price is $34.09 per share, the November 6 New York Stock Exchange closing price, and the repurchase is expected to close on November 10, 2026, subject to customary closing conditions.
Per-share price of $34.09, equal to the NYSE closing price on November 6, 2026
Aggregate purchase price of approximately $110 million
Expected closing on November 10, 2026, subject to customary closing conditions
Agreement is with Argon Holdco LLC and is filed as Exhibit 10.1
Hyatt Hotels filed a Regulation FD disclosure on lock-up restrictions covering its Class A and Class B shares. Based on current agreements, 14,685,256 restricted shares held by Pritzker family stockholders will be available for public sale from November 5, 2026 through November 4, 2027, which could add supply to the stock market.
14,685,256 restricted shares held by Pritzker family stockholders may be sold from November 5, 2026 to November 4, 2027
2,270,395 additional restricted Class B shares held by other 2007 Stockholders' Agreement parties are available for sale at any time, subject to Company rights of first refusal
An additional 2,678 restricted shares are not subject to lock-up restrictions
Nexentis Technologies Inc. effected a 1-for-5 reverse stock split of its common stock, under authority approved by stockholders on April 30, 2026. The split took effect at 4:15 p.m. Eastern Time on November 6, 2026, and the stock will trade on a split-adjusted basis on the Nasdaq Capital Market from November 9, 2026, under the existing symbol NXTS. The company said the split is intended to raise the per-share price and bid price to regain compliance with Nasdaq continued listing requirements.
Every 5 outstanding shares converted into 1 share; per-share exercise prices and option and warrant share counts adjusted proportionately
Outstanding shares to fall from approximately 2.9 million to approximately 600 thousand, per the press release
Trading begins on a split-adjusted basis November 9, 2026, under new CUSIP 80512Q709
Authorized common stock unchanged at 495,000,000 shares; fractional shares rounded up to the next whole share
Realty Income's Compensation and Talent Committee adopted the 2026 Promote Award Plan on November 3, 2026. The plan lets employees, including named executive officers, earn bonuses tied to incentive allocations from certain investment funds and joint ventures the company manages, with bonus pools capped at 40% of each allocation. The filing gives no dollar amounts for awards, so shareholder cost cannot be sized from this document.
Plan adopted November 3, 2026 by the Compensation and Talent Committee
Bonus pools may not exceed 40% of the incentive allocation for each measurement period
Executive bonuses paid in stock-based awards; 50% vests at grant and 50% after one year, unless the Committee decides otherwise
Filing includes the plan and form of RSU award agreement as Exhibits 10.1 and 10.2
Align Technology entered an accelerated share repurchase agreement with Goldman Sachs to buy back $270 million of its common stock, funded with cash on hand. The company expects to complete the transaction by about December 29, 2026, and says the deal brings its total 2026 share repurchases to approximately $500 million.
ASR of $270 million, with a $270 million prepayment to Goldman Sachs made under the agreement dated November 5, 2026
Initial delivery of approximately 1.44 million shares; final share count depends on volume-weighted average price less a discount
Approximately $330 million remains under the $1.0 billion repurchase program after this transaction; cash and equivalents were about $1.145 billion as of September 30, 2026
Final settlement expected no later than about December 29, 2026
Crown Castle's Board declared a quarterly cash dividend of $1.0625 per common share, payable December 31, 2026, to holders of record at the close of business on December 15, 2026. The filing contains no earnings, guidance, or other financial results, and the dividend remains subject to future Board approval.
Dividend: $1.0625 per common share, quarterly cash dividend
Record date: close of business December 15, 2026
Payment date: December 31, 2026
Future dividends remain subject to Board of Directors approval
Lindsay Corporation entered into a cooperation agreement with activist investor Vision One Fund, LP, under which it will nominate Marvin E. Washington as an independent director at its fiscal 2027 annual meeting and seek stockholder approval to declassify the board. Vision One withdrew its October 5, 2026 stockholder proposals and director nominations and agreed to standstill provisions, which would limit its actions in the company's governance.
Marvin E. Washington to be nominated as independent director at the fiscal 2027 annual meeting, with a term expiring at the fiscal 2030 annual meeting
Washington expected to join the Audit Committee; board size capped at nine directors until the termination date
Board declassification proposals to be voted on at the fiscal 2027 annual meeting, with annual elections fully in place by the fiscal 2030 annual meeting
Vision One withdrew its October 5, 2026 notice of proposals and nominations and agreed to a standstill, including a 4.9% ownership cap
Arch Capital Group increased its existing share repurchase authorization by $3.0 billion, leaving about $3.6 billion available as of November 5, 2026. The board also declared quarterly dividends on its Series F and Series G non-cumulative preferred shares, payable December 31, 2026, to holders of record as of December 15, 2026.
Share repurchase authorization increased by $3.0 billion; about $3.6 billion available as of November 5, 2026
Series F preferred dividend of $0.340625 per share, totaling $4,496,250, for the period 9/30/26 to 12/30/26
Series G preferred dividend of $0.284375 per share, totaling $5,687,500, for the same period
All dividends payable December 31, 2026 to holders of record as of December 15, 2026
Spruce Power Holding Corporation changed its legal domicile from Delaware to Texas effective October 30, 2026, and its common stock continues to trade on the NYSE under SPRU. The filing says the move did not change the company's headquarters, business, management, employees, assets, liabilities or net worth, apart from transaction costs and franchise taxes, and that stockholders do not need to exchange their shares.
Redomiciliation became effective October 30, 2026; each Delaware share converted automatically into one Texas share.
Company is now governed by a Texas certificate of formation and new bylaws approved by its Board.
Certain stockholder rights changed; details are in the June 23, 2026 proxy statement, Proposal Four, pages 41 to 73.
OFA Group said it will consolidate its Class A ordinary shares at a 10-for-1 ratio effective November 10, 2026, to support its continued listing on the Nasdaq Capital Market. Shareholders do not need to take action, as positions will be adjusted automatically, but the number of shares outstanding falls from 9,000,910 to about 900,093.
Effective 12:01 a.m. Eastern Time on November 10, 2026; shares trade split-adjusted under symbol OFAL with new CUSIP G6713S122
Class A shares outstanding fall from 9,000,910 to approximately 900,093, with fractional shares rounded up
Approved by shareholders at an annual general meeting on October 5, 2026, and by the Board on October 26, 2026
Processa sent a stockholder letter on November 5, 2026, reviewing its July acquisition of Vidya Therapeutics and the concurrent private placement of approximately $200 million. The letter says the approximately 2.8 million common shares outstanding represent only a small part of an expected 309.3 million-share as-converted count after Series A preferred conversion, which is subject to stockholder approval. Stockholders must vote separately at two special meetings, and the company says the July financing is expected to fund operations into the second half of 2029.
The Vidya acquisition and private placement closed in July; the financing generated approximately $183.3 million in net proceeds.
Expected capitalization: 2.8 million common shares outstanding plus 306.5 million Series A preferred as-converted, for 309.3 million total, subject to stockholder approval.
Definitive proxy materials for the first special meeting were filed October 22, 2026, and mailing has commenced; the second meeting's proxy is forthcoming.
The FDA cleared the IND for a planned Phase 2 clinical trial of VT-7208 in chronic spontaneous urticaria.
InMed Pharmaceuticals, now named Mentari Therapeutics, Inc., reported that shareholders approved all ten proposals at its November 4, 2026 meeting, including a Nasdaq share issuance tied to the pending Mentari merger. The company also completed a 1-for-10 share consolidation, cutting common shares from 5,493,735 to about 549,374, and will trade under INM from November 5, 2026. The change lowers the share count and per-share figures, and creates Series A non-voting preferred shares that carry board-election and conversion terms.
Shareholders approved the Nasdaq share issuance for the Mentari merger with 2,615,030 votes for, 97.295% of votes cast.
Common shares were consolidated from 5,493,735 to about 549,374, with trading under INM expected from November 5, 2026 under new CUSIP 457637809.
4,013 preferred shares were designated as Series A Non-Voting Preferred, each convertible into 1,000 common shares, with a 19.99% ownership cap.
Shareholders approved redomestication from British Columbia to Nevada with 88.825% votes for; a CVR distribution record date of November 5, 2026 was set.
The board approved an amendment that lets Comfort Systems USA repurchase up to 1,000,000 more shares beyond what it had bought through November 4, 2026. Through that date, the company had repurchased 11,752,570 shares for $1.71 billion, excluding excise tax. The filing does not give a timing for purchases, but the added capacity could reduce the share count for existing shareholders.
Board approved an amendment authorizing up to 994,606 additional shares, which tops off the plan to 1,000,000 shares beyond purchases made through November 4, 2026.
Through November 4, 2026, the company repurchased 11,752,570 shares at an aggregate price of $1,711,769,315, excluding excise tax.
The original program authorized up to 11,757,964 shares.
Purchases will be funded with available cash, in the open market or privately negotiated transactions, and the board may modify, suspend, extend or terminate the program at any time.
HF Sinclair agreed to buy back 2,100,000 shares of its common stock from REH Advisors Inc. at $110.81 per share, for an aggregate price of approximately $233 million, funded with cash on hand. The repurchase is expected to close on or around November 6, 2026, and is made under the company's $1.5 billion share repurchase program, which leaves about $493 million of authorization remaining.
2,100,000 shares at $110.81 per share, for an aggregate price of approximately $233 million, funded with cash on hand
Stock Purchase Agreement dated November 3, 2026; expected completion on or around November 6, 2026
Made under the $1.5 billion share repurchase program authorized by the Board on August 26, 2026; about $493 million remains, and $1 billion has been repurchased to date including this transaction
Shares will be held as treasury stock; this is the twenty-fourth privately negotiated transaction between the company and REH
FACT II Acquisition Corp. moved its extraordinary general meeting from November 10 to November 17, 2026, to allow more time to engage with shareholders. The redemption request deadline was extended from November 6 to November 13, 2026, giving shareholders more time to decide whether to redeem their shares ahead of the vote on extending the deadline for a business combination to November 25, 2027.
Shareholder meeting moved from November 10, 2026 to November 17, 2026, at 10:00 a.m. Eastern Time
Redemption request deadline extended from 5:00 p.m. Eastern Time on November 6, 2026 to November 13, 2026
Extension Amendment Proposal would move the business combination deadline to November 25, 2027
In-person attendance reservations due by 10:00 a.m. Eastern Time on November 13, 2026
CBL & Associates Properties' Board of Directors authorized a new common stock repurchase program of up to $25.0 million, which replaces the program authorized on November 5, 2025. The company may buy shares on the open market, in privately negotiated transactions or otherwise through December 31, 2027, depending on market prices and other conditions. The filing does not commit the company to any particular amount of repurchases.
Program authorizes up to $25.0 million of common stock repurchases.
Replaces the existing program authorized on November 5, 2025.
Purchases may be made through December 31, 2027, and the program may be suspended or discontinued at any time.
CEO Stephen D. Lebovitz cited a cash balance of over $366.0 million and no major debt maturities until 2028.
Ingram Holdco, an affiliate of Platinum Equity, sold 11,000,000 Ingram Micro common shares in a secondary offering priced at $25.90 per share, with Goldman Sachs & Co. LLC as sole underwriter. Ingram Micro is not selling any shares and receives none of the proceeds, but it is repurchasing 1,000,000 shares from the underwriter as part of the offering, which leaves $27,251,500 of capacity under its existing $175 million repurchase program.
Selling stockholder Ingram Holdco, LLC sold 11,000,000 shares at $25.90 per share, priced November 2, 2026.
The underwriter exercised in full its option to buy 1,650,000 more shares on November 3, 2026.
Ingram Micro is repurchasing 1,000,000 shares from the underwriter, funded with cash on hand, under its existing $175 million program.
The offering is expected to close on or about November 4, 2026; the company receives none of the offering proceeds.
Accuray's board approved a 1-for-40 reverse stock split of its common stock, effective at 12:02 a.m. Eastern Time on November 9, 2026, with shares continuing to trade on Nasdaq under ARAY. The press release says the split is intended to raise the per-share trading price and help the company regain compliance with Nasdaq's minimum bid price requirement; shareholders keep the same percentage ownership, except for cash paid in lieu of fractional shares.
Every 40 shares of common stock will combine into one share; outstanding shares fall from approximately 120.2 million to approximately 3.0 million.
Authorized common stock falls from 400,000,000 to 10,000,000 shares; new CUSIP is 004397 303.
Trading on a split-adjusted basis begins when Nasdaq opens on November 9, 2026; Computershare is the exchange agent.
Monro amended its Rights Agreement to extend the final expiration date from 5:00 p.m. Eastern Time on November 6, 2026 to 5:00 p.m. Eastern Time on November 1, 2027, unless the rights are earlier redeemed, exchanged or terminated. The Board said the extension supports the company's ongoing review of strategic alternatives and is intended to preserve its ability to conduct that review and protect the company and its shareholders.
Final expiration date moves from November 6, 2026 to November 1, 2027.
Amendment dated November 4, 2026, with Equiniti Trust Company, LLC as rights agent.
Original Rights Agreement is dated November 10, 2025.
Board cites the ongoing review of strategic alternatives as the reason for the extension.
Viasat's board committee adopted the Viasat Value Creation Incentive Program (V-CIP), which grants performance-based restricted stock units that vest only if the stock reaches price hurdles between $150 and $300 through 2030. The committee expects to approve initial awards in December 2026 and plans to allocate a significant portion to Chairman and CEO Mark Dankberg, which may matter to shareholders given potential dilution from the shares involved.
Initial awards of up to 2.8 million PSUs expected, assuming the highest hurdle is met
Price hurdles of $150, $188, $225, $263 and $300, versus a $74.11 close on November 2, 2026
Performance period ends December 31, 2030, with a four-year service-based vesting requirement
Jasper Therapeutics, Nasdaq-listed as JSPR, filed a charter amendment to carry out a 1-for-30 reverse stock split, which takes effect at 12:01 a.m. Eastern Time on November 6, 2026. Each stockholder's percentage ownership is unchanged apart from minor fractional-share adjustments, but the number of shares outstanding falls from about 33.3 million to about 1.1 million.
Ratio of 1-for-30 was set by the board on October 23, 2026, within the 1-for-15 to 1-for-35 range stockholders approved on September 30, 2026.
Shares outstanding fall from about 33.3 million to about 1.1 million; authorized shares stay at 490,000,000.
Cash will be paid in lieu of fractional shares based on the November 5, 2026 closing price.
Trading continues under JSPR on the Nasdaq Capital Market with new CUSIP 471871301.
Bluejay Diagnostics (Nasdaq: BJDX) completed a 1-for-4 reverse stock split effective November 3, 2026. The Board selected the ratio from a range of 1-for-2 to 1-for-20 that stockholders approved in June, and the cut reduced common shares outstanding from about 4,468,051 to about 1,117,013. The par value and voting rights are unchanged, and holders of fractional shares will receive cash, but the press release describes a three-for-one combination while the 8-K describes four-for-one, so the terms should be confirmed with the transfer agent.
Split effective 12:01 a.m. Eastern Time on November 3, 2026; BJDX began trading post-split on the Nasdaq Capital Market under new CUSIP 095633707.
Common shares outstanding fell from about 4,468,051 to about 1,117,013; prefunded warrant shares fell from 222,581 to 55,646 (press release says 55,645).
Stockholders approved the split at the June 9, 2026 annual meeting; the Board chose 1-for-4 and the certificate was filed October 30, 2026.
Fractional-share holders receive cash based on the recent average closing price; the press release describes every three shares combining into one, conflicting with the 8-K's four-for-one terms.
Bio-Techne's board declared a $0.08 per share cash dividend for the quarter ended September 30, 2026. The payment is conditional on the pending transaction with Merck KGaA, Darmstadt, Germany not closing on or before the November 13, 2026 record date, so the dividend tie-in to that deal matters to shareholders.
Dividend of $0.08 per share for the quarter ended September 30, 2026
Payable November 23, 2026 to common shareholders of record at close of business November 13, 2026
Dividend applies only if the Merck KGaA transaction has not closed on or before November 13, 2026
Future dividends will be considered by the Board on a quarterly basis
Avidia Bancorp, Inc. completed its previously reported plan to repurchase up to $30 million in value of its common stock on November 3, 2026. The company bought 1,355,565 shares at a weighted average price of $22.10 per share, excluding commissions and excise taxes, which reduces the number of shares outstanding for existing shareholders.
Buyback plan of up to $30 million in value completed on November 3, 2026
1,355,565 shares repurchased at a weighted average price of $22.10 per share
Price excludes commissions and excise taxes; filing made under Item 8.01 (Other Events)
At its October 29, 2026 annual meeting, Autonomix Medical stockholders approved an increase of 750,000 shares under the 2023 Stock Plan and authorized the board to seek a reverse stock split of between 1-for-2 and 1-for-25. All six director nominees were elected, and Forvis Mazars, LLP was ratified as the independent auditor for the year ending March 31, 2027. The votes give the board flexibility on share count and equity awards, but the filing does not say whether a reverse split will be pursued.
Annual meeting held October 29, 2026; 905,610 shares voted, about 46% of 1,959,938 shares outstanding as of the September 8, 2026 record date.
2023 Stock Plan amended to add 750,000 shares; total issuable under the plan is 750,353 shares.
Reverse split proposal approved with 775,257 votes for and 110,036 against, authority valid until the one-year anniversary of the meeting.
Plan amendment approved with 225,651 votes for and 39,672 against.
On November 3, 2026, the Board of Directors of National Bank Holdings Corporation declared a cash dividend of $0.33 per share on its Class A common stock. The press release describes the payment as an increase to the quarterly dividend, but the filing does not state the prior amount. Future dividends remain subject to Board approval and will depend on the company's financial position, results and capital requirements.
Cash dividend of $0.33 per share on Class A common stock, declared November 3, 2026
Record date is November 27, 2026 (close of business); payment date is December 15, 2026
Press release, filed as Exhibit 99.1, calls it an increase to the quarterly dividend; prior dividend amount not stated
Future dividends are at the Board's discretion and depend on financial position, results, cash flows and capital requirements
TXO Partners, L.P. said its general partner declared a third-quarter 2026 distribution of $0.44 per common unit for the quarter ended September 30, 2026. Unitholders of record at the close of trading on November 13, 2026, will receive the payment on November 20, 2026, and the filing includes no new earnings or revenue figures. The company also posted an investor presentation on its website, which it furnished as an exhibit.
Distribution of $0.44 per common unit for the quarter ended September 30, 2026
Record date November 13, 2026; payment date November 20, 2026
Quarterly Report on Form 10-Q for the same quarter to be filed on November 3, 2026
Investor presentation dated November 2026 posted to the company website
On October 31, 2026, Enhanced Group Inc. amended Transaction Support Agreements with its controlling shareholder Enhanced Holdings LP, CEO Maximilian Martin and Aron D'Souza. The amendments remove the six-month lock-up release for these holders, so their remaining locked-up Class A shares stay restricted until twelve months after the May 7, 2026 business combination closing. The filing also confirms a one-for-ten reverse stock split that took effect October 29, 2026.
Amendments dated October 31, 2026 cover Enhanced Holdings LP, Maximilian Martin (CEO) and Aron D'Souza.
The six-month lock-up release is eliminated for these supporting shareholders; remaining shares stay locked until twelve months after the May 7, 2026 closing.
Transaction Support Agreements with the company's other shareholders were not amended.
The one-for-ten reverse split of Class A and Class B common stock took effect October 29, 2026, and Class A shares continue to trade as ENHA on the NYSE.
Commerce Bancshares' Board of Directors approved a new share repurchase program of up to 7,500,000 shares of common stock, combined with the amount remaining from the prior authorization of April 24, 2026. The company announced the approval in a press release dated November 3, 2026, filed as Exhibit 99.1. The filing does not state the dollar value of the program or the timing of purchases, so shareholders can see the size in shares but not its cost.
Board approved repurchase of up to 7,500,000 total shares of common stock
Total includes the amount remaining from the prior authorization approved April 24, 2026
Announced in a press release dated November 3, 2026 (Exhibit 99.1)
Filing does not state a dollar amount or purchase timeline
XMax Inc. announced a share repurchase program of up to $30 million, with purchases allowed only below $5.50 per share. The program will not start until after the company releases its results for the quarter ended September 30, 2026, discloses any material nonpublic information, and engages a broker-dealer, and it will expire three months after it begins. For shareholders, the program is a potential source of buying support for the stock, funded from existing cash, but the company is not obligated to buy any particular amount.
Up to $30 million in aggregate purchase price of common stock, approved by the Board on October 31, 2026
Repurchases allowed only at prices below $5.50 per share
Start date to be determined after the Q3 2026 Earnings Release; program expires three months after commencement
Funded from existing cash and cash equivalents; no obligation to repurchase any amount
Guardant Health's board approved performance-based restricted stock unit awards to co-CEOs Helmy Eltoukhy and AmirAli Talasaz, each with a target of 465,413 PSUs. The awards pay out only if the company's total shareholder return beats a set percentile versus S&P 500 constituents over three-year and five-year periods, so the grants create no value unless relative returns meet those thresholds.
Each co-CEO received a grant of 465,413 PSUs at target, approved November 2, 2026.
25% of target PSUs cover a three-year period (June 1, 2026 to May 31, 2029); 75% cover a five-year period (June 1, 2026 to May 31, 2031).
Payout ranges from 0% of target below the 40th percentile to 250% at or above the 90th percentile; total vesting is capped at 250% of target.
Cooper-Standard's board adopted a Section 382 rights agreement that replaces the company's existing rights plan when that plan expires, effective the close of business on November 5, 2026. The plan is meant to protect the company's net operating loss carryforwards and other tax attributes from being limited by a future ownership change, and it would deter any person from acquiring 4.9% or more of the common stock without board approval.
Rights plan takes effect at the close of business on November 5, 2026, replacing the expiring existing plan.
Rights are distributed to holders of record on November 12, 2026, at one right per common share, exercisable at $100.
Rights become exercisable if a person or group acquires 4.9% or more of the common stock; holders above 4.9% at adoption are not deemed acquiring persons.
The company estimates U.S. Tax Benefits at approximately $215 million as of September 30, 2026; the plan expires November 1, 2029, or November 1, 2027 if stockholder approval is not obtained, and will be submitted for ratification at the 20
PROG Holdings entered into a $100 million accelerated share repurchase program with Bank of America on October 29, 2026, paying the full amount up front for an initial delivery of about 2.59 million shares. The final share count depends on volume-weighted average prices during the program, which is expected to settle by the end of the first quarter of 2027.
Repurchase size: $100 million, paid to Bank of America on October 29, 2026
Initial delivery: approximately 2.59 million shares of common stock
Final settlement expected by the end of the first quarter of 2027
Funded with existing cash and borrowings under the company's credit agreement
Copley Acquisition Corp has moved its extraordinary general meeting from October 29 to November 2, 2026, to seek shareholder approval of an extension of its deadline to complete a business combination by up to 12 one-month periods, through November 2, 2027. The sponsor raised its contribution to the trust account from $150,000 to $200,000 per monthly extension, and the company waived its right to withdraw up to $100,000 of trust interest for dissolution expenses and interest for tax expenses, which the filing says is meant to give holders who voted against the proposals time to reverse their votes.
Meeting adjourned from 11:00 a.m. Eastern on October 29, 2026, to 11:00 a.m. Eastern on November 2, 2026.
Proposed extension allows up to 12 monthly extensions, from November 2, 2026, to November 2, 2027.
Sponsor's contribution per one-month extension revised from $150,000 to $200,000.
Company waived its right to withdraw up to $100,000 of trust interest for dissolution expenses and interest for tax expenses.
K&F Growth Acquisition Corp. II moved its extraordinary general meeting from November 3 to November 4, 2026, and extended the shareholder redemption deadline to November 2, 2026. It also amended its proposed extension so the end date is August 6, 2027, instead of February 7, 2028, and entered non-redemption agreements with investors that the company says are expected to increase the funds remaining in its trust account.
Meeting moved from Tuesday, November 3, 2026 to Wednesday, November 4, 2026, at 11:00 a.m. Eastern Time
Redemption deadline extended to Monday, November 2, 2026, at 5:00 p.m. Eastern Time
Proposed extension end date changed from February 7, 2028 to August 6, 2027
Non-redemption agreements provide one surviving company share per six public shares not redeemed if the business combination closes by May 6, 2027, and one per thirty public shares if it closes later
HF Sinclair agreed to repurchase 2,350,000 common shares from its largest holder, REH Advisors Inc., at $109.37 per share, or about $257 million in total, with completion expected on or around November 3, 2026. The filing says the REH Parties are expected to fall below the 5%-to-15% ownership range that gives them a right to designate a Board member, which could lead to that designee offering to resign by early 2027.
Shares: 2,350,000 common shares at $109.37 each, about $257 million total, funded with cash on hand
Expected completion: on or around November 3, 2026; shares will be held as treasury stock
Program status: $766 million repurchased to date under the $1.5 billion program authorized August 26, 2026, leaving about $734 million
Board: REH Designee must offer to resign within 30 days after January 13, 2027 if REH Parties remain below the 15% designation threshold
At a special meeting on October 30, 2026, Change Agents Corporation stockholders approved all 17 proposals, including issuances of common stock tied to financing and consulting arrangements, an increase in authorized common shares from 100 million to 125 million, and a higher share reserve under the stock incentive plan. The approvals allow the company to issue additional shares, which could dilute existing shareholders' ownership.
Stockholders approved all 17 proposals at the special meeting held October 30, 2026, with 406,853 shares represented, constituting a quorum.
The charter amendment raising authorized common stock from 100,000,000 to 125,000,000 shares received 349,819 votes for and 55,844 against.
The stock incentive plan amendment increases the shares reserved for issuance from 100,000 to 500,000 shares; it received 146,588 votes for and 10,434 against.
Share issuances approved under Nasdaq Listing Rule 5635(d) cover the Hudson Global Ventures equity purchase agreement, Vanquish Funding Group notes, and several consulting and warrant arrangements.
Nexstar Media Group's Board of Directors declared a quarterly cash dividend of $1.86 per share on its common stock, announced October 30, 2026. The dividend is payable November 27, 2026 to holders of record on November 13, 2026. The company says it intends to pay regular quarterly dividends, but future dividends will be reviewed and declared by the Board at its discretion.
Quarterly cash dividend of $1.86 per share declared October 30, 2026
Payable Friday, November 27, 2026
Record date is Friday, November 13, 2026
Future dividends, including increases, remain subject to quarterly Board review and discretion
Hilton Grand Vacations agreed on October 30, 2026 to repurchase $200 million of its common stock through an accelerated share repurchase with Deutsche Bank AG, London Branch. The company paid $200 million up front and received an initial delivery of approximately 4.48 million shares, with the final share count to be set at settlement based on volume-weighted average price, less a discount.
Company pays $200 million to the Dealer on October 30, 2026 and receives an initial delivery of approximately 4.48 million shares.
Final share count depends on the volume-weighted average price over the calculation period, less a discount; the Dealer may deliver additional shares at settlement.
Final settlement is expected no later than December 31, 2026, and the Dealer may accelerate the termination date on or after December 1, 2026.
On October 29, 2026, Jones Lang LaSalle entered into a confirmation with Wells Fargo Bank for an accelerated share repurchase of $500 million of its common stock. The buyback is being made under the company's previously announced share repurchase program, so it reflects capital already authorized by the board.
Size of the accelerated share repurchase: $500 million of common stock
Counterparty: Wells Fargo Bank
Executed October 29, 2026, under the previously announced share repurchase program
Filing signed by CFO Kelly Howe on October 30, 2026
Celestica said the Toronto Stock Exchange accepted its normal course issuer bid to repurchase up to 3,132,127 common shares, about 2.5% of its public float, over the next 12 months. Purchases are set to begin November 3, 2026 and end by November 2, 2027, and will be funded from existing cash and its credit facility or other available debt, with repurchased shares cancelled. For shareholders, the bid is a potential use of capital that could reduce the share count, though the company has not committed to buying the full amount.
Up to 3,132,127 common shares, about 2.5% of the public float as of October 20, 2026
Purchases scheduled to run from November 3, 2026 to the earlier of November 2, 2027 or completion of the bid
Daily TSX purchases limited to 109,076 shares, based on average daily volume for the six months ended September 30, 2026
Prior bid expires November 2, 2026; the company had repurchased and cancelled 205,184 shares at a weighted average price of US$271.75
Dine Brands' board adopted a limited duration stockholder rights agreement on October 28, 2026, in response to media reports of significant open market accumulation in its stock and derivatives. The plan issues one right per common share to holders of record on November 9, 2026, and the rights generally become exercisable only if a person or group acquires 10% or more (20% for passive investors) without board approval.
Rights dividend: one right per common share, record date November 9, 2026
Exercise price of $210.00 per right, subject to adjustment; rights expire October 27, 2027 unless redeemed or exchanged earlier
Triggers at 10% beneficial ownership for non-passive investors and 20% for passive investors; the company may redeem rights at $0.001 each
Filing states stockholders are not required to take any action at this time
Business First Bancshares, Inc. said its Board of Directors approved a stock repurchase program of up to $30 million of common stock, running from Oct. 29, 2026 to Oct. 28, 2028. The company is not obligated to buy any shares, and the Board may modify, suspend or end the program at any time, so the effect on shareholders depends on how much is actually repurchased.
Authorizes repurchases with an aggregate purchase price of up to $30 million
Program period runs 24 months, from Oct. 29, 2026 to Oct. 28, 2028
Repurchases may be made in the open market under SEC Rule 10b-18 or through privately negotiated transactions
No obligation to repurchase; the Board may modify, suspend or terminate the program at any time
At an annual meeting on October 29, 2026, Stellar V Capital Corp. shareholders approved an amendment extending the deadline to complete a business combination from October 31, 2026 to July 31, 2027, or an earlier date set by the board. The company also entered non-redemption agreements with certain shareholders intended to keep more funds in its trust account, under which those investors may receive Class A ordinary shares at no additional cost after a business combination closes.
Combination Period extended from October 31, 2026 to July 31, 2027, or an earlier date set by the board
Non-redemption agreements: eligible investors may receive one Class A ordinary share for every five Investor Shares held, after closing of an initial business combination
Agreements terminate on events including failure of the extension vote, liquidation, or mutual agreement
Form of Non-Redemption Agreement filed as Exhibit 10.1
Zone Frontier Inc. (ZONE) filed a Certificate of Change on October 23, 2026 to effect a 1-for-60 reverse stock split of its common stock, effective 9:01 p.m. Pacific Time on October 29, 2026, with split-adjusted trading expected on NYSE American from October 30 under the same symbol. The filing also reports the departures of President Travis Buchanan and Chief Revenue Officer Gary Hollst, whose roles related solely to the sold Cleaning Products Business, with severance payments of $150,000 and $125,000 respectively.
Every 60 shares of common stock will combine into one share; a new CUSIP number, 184492205, applies.
Authorized common stock falls from 6,942,000,000 to 115,700,000 shares; authorized blank check preferred falls from 50,000,000 to 833,334 shares.
Travis Buchanan (President) and Gary Hollst (Chief Revenue Officer) left effective October 23, 2026; severance is $150,000 and $125,000 respectively.
The departures followed the October 7, 2026 sale of the Cleaning Products Business to Sanzonate Holdings LLC; the company said neither role had responsibility for its data center development business.
TEN Holdings, Inc. (XHLD) adjourned its 2026 Annual Meeting of Stockholders on October 29, 2026, because not enough shares were present or represented by proxy to form a quorum, so no business was conducted. The meeting will reconvene on November 12, 2026, with the proposals and September 4, 2026 record date unchanged, giving stockholders more time to cast votes on the director elections and auditor ratification.
Annual meeting convened and adjourned October 29, 2026 without any business being conducted due to lack of quorum.
Meeting reconvenes November 12, 2026 at 9:00 a.m. Eastern Time via live webcast.
Proposals: elect four directors and ratify AssentSure PAC as independent registered public accounting firm for fiscal year ending December 31, 2026.
Record date remains the close of business on September 4, 2026; the Proxy Statement filed September 10, 2026 is unchanged.
Glacier Bancorp's Board of Directors approved a share repurchase program on October 29, 2026, authorizing purchases of up to $200 million of its common stock through December 31, 2027. The filing says the company may buy shares in the open market, in block trades, or in privately negotiated transactions, with timing and volume at management's discretion.
Program authorizes up to $200 million of common stock repurchases through December 31, 2027
Purchases may be made in the open market, in block trades, or in privately negotiated transactions
The program does not require any minimum number of shares to be repurchased
Filing says the CEO, CFO, and Deputy CFO are authorized to direct purchases
On October 28, 2026, Strategy Inc stockholders approved amended certificates of designations for its STRF, STRC, STRK and STRD preferred stock to permit daily dividends. The company says the changes do not alter total regular dividend amounts or dividend rates, and the STRC change takes effect November 1, 2026, while the others take effect January 1, 2027.
Proposal 1 passed at the October 28, 2026 Special Meeting with 381,373,199 votes for, 2,236,551 against and 444,753 abstentions.
The Second A&R STRC Stock CoD takes effect at 12:01 a.m. Eastern Time on November 1, 2026; the STRF, STRK and STRD amendments take effect January 1, 2027.
Because the contingent condition is met, November daily STRC dividends will be payable, and the semi-monthly STRC dividend payable November 15, 2026 will not be payable.
Global Partners LP's board declared a quarterly cash distribution of $0.7850 per common unit for the July 1 to September 30, 2026 period, or $3.14 per unit annualized. Unitholders of record as of November 9, 2026 will receive the payment on November 13, 2026. The filing is a routine distribution announcement and does not report financial results, so it gives no new information on earnings or guidance.
Quarterly distribution of $0.7850 per common unit, $3.14 annualized
Covers the period July 1, 2026 through September 30, 2026
Record date November 9, 2026; payment date November 13, 2026
Brokers were told to treat 100% of distributions to non-U.S. investors as effectively connected income subject to withholding
DXP Enterprises' Board authorized a new program to repurchase up to $150.0 million or 1.0 million shares of common stock over the next 24 months, at management's discretion. The new program follows a previous $85.0 million or 2.5 million share program that concluded in August 2026, and the company may discontinue it at any time.
Up to $150.0 million or 1.0 million shares may be repurchased over the next 24 months
Previous program authorized up to $85.0 million or 2.5 million shares and concluded in August 2026
Approximately 16.4 million diluted weighted average shares outstanding as of June 30, 2026
Repurchases may occur in open market or privately negotiated transactions; no guarantee of exact amount
Jaguar Health filed a supplement to its proxy statement for the November 6, 2026 special meeting, disclosing a six-fold increase in shares available under its 2014 Stock Incentive Plan. The adjustment offsets dilution from the Series R Preferred Stock dividend and conversion, and it takes effect after the meeting if stockholders approve Proposal 3. Shareholders should note that the filing does not change the proposals or the board's recommendations.
Share Reserve Adjustment raises 2014 Plan shares to 2,273,154 if Proposal 3 is approved, up from 378,859 proposed in the proxy statement
Without approval, the 2014 Plan would have 4,260 shares available, up from 710 shares, per the filing
Series R Preferred Stock converts to five common shares per preferred share on November 2, 2026
Churchill Downs' board approved a $750 million share buyback that replaces the prior $500 million program from July 2025. The new authorization includes the $306 million remaining under the old program as of October 27, 2026, and has no time limit.
New repurchase program authorized at $750 million, announced October 27, 2026.
Replaces the $500 million program authorized in July 2025; $306 million remained under it at the close of trading on October 27, 2026.
Repurchases may be made in the open market, with or without a 10b5-1 plan, or through privately negotiated transactions, and may be suspended or discontinued at any time.
On October 26, 2026, Playboy amended its backstop agreement so that The Million S.a.r.l., an affiliate of Byborg Enterprises SA and director György Gattyán, must buy all 4,761,905 shares scheduled under the repurchase agreement by November 1, 2026, for $5,000,000.25 in cash. Rizvi Master LLC's commitment on those shares was reduced to zero, and neither backstop purchaser will receive a backstop fee on them. The amendment was approved by the board and Audit Committee, and the sellers and the senior credit facility agent consented.
Amendment No. 1 to the Backstop Agreement dated October 26, 2026; The Million must buy the 4,761,905 Tranche 3 Shares on or before November 1, 2026
Aggregate cash consideration of $5,000,000.25, payable on or before November 1, 2026
Rizvi's purchase commitment reduced to zero; no backstop fee to either party on Tranche 3 Shares
Approved by the board and Audit Committee; DBD Credit Funding LLC gave prior written consent
FirstCash's board increased the company's stock repurchase authorization by $200 million, bringing the total program to $350 million, of which $128 million had been used to date. The company said $222 million remains under the current program as of the October 28, 2026 market open, and CEO Rick Wessel cited the gap between the current valuation and the company's growth progress as the reason.
Authorization increased by $200 million to a total of $350 million
$128 million used to date, buying 644,000 shares at an average price of $199.46
$222 million remains available as of the October 28, 2026 market open
No time limit set; the program may be suspended or discontinued at any time
At a Special Meeting on October 28, 2026, Strategy Inc stockholders approved amended certificates of designations for four preferred stock series to permit daily dividends. Under the new schedule, STRC dividends begin November 1, 2026 and STRF, STRK and STRD dividends begin January 1, 2027, subject to the filing and effectiveness of the amended certificates. Holders should note that record and ex-dividend dates will fall on weekends and holidays, which changes how dividend entitlement works for trades on those days.
Special Meeting held October 28, 2026; requisite vote obtained based on preliminary results, with a record date of September 25, 2026
Daily dividend schedule effective November 1, 2026 for STRC Stock and January 1, 2027 for STRF, STRK and STRD Stock
Dividend record dates fall on every calendar day; for DTC-cleared shares, weekend or holiday record dates move to the prior non-holiday
Company expects investors buying on Friday, November 6, 2026 will not receive dividends with record dates of November 6, 7 and 8, 2026
People Incorporated, Barry Diller and MGM Resorts International amended their April 3, 2026 Voting Agreement on October 27, 2026. The amendment caps People and Mr. Diller's combined MGM ownership at 29.9% of common stock, adds voting and anti-defense commitments, and clarifies when a change of control occurs.
Covered Entities may hold up to 29.9% of MGM's outstanding common stock, with exceptions for MGM-driven share reductions
Voting obligation applies above a 25.73% voting power threshold on non-change-of-control matters
MGM agreed not to adopt defensive measures primarily aimed at the Covered Entities, and a majority-stake acquisition by them is not a change of control unless the Board approves it
MGM Resorts amended its April 3, 2026 Voting Agreement with People Incorporated and Barry Diller on October 27, 2026, after People withdrew its previously announced proposal to acquire the company. The amendment caps the group's ownership at 29.9% of outstanding common stock and sets voting rules for stockholder votes and change of control transactions. The company says no transaction is contemplated under the agreement.
Covered Entities may not acquire shares that would take their ownership above 29.9% of outstanding common stock, with exceptions for increases caused by company repurchases.
Above 25.73% of voting power, the Covered Entities vote in line with the majority of other holders on non-change-of-control matters.
In a change of control transaction, they vote with the Board's recommendation if specified conditions are met.
The amendment followed People's withdrawal of its proposal to acquire MGM Resorts; the press release was issued October 28, 2026.
Kochav Defense Acquisition Corp. said its sponsor, Kochav Sponsor LLC, will contribute cash to the company's trust account if shareholders approve the proposed extension of the deadline to complete an initial business combination. The original proxy statement did not include any sponsor contribution. The cash would go to public shareholders whose shares are not redeemed, and the sponsor also plans to convert 8,433,332 Class B shares into Class A shares.
Extension vote is set for the extraordinary general meeting on November 13, 2026, at 10:00 a.m. Eastern time; record date is October 13, 2026.
Sponsor to deposit $0.06 per non-redeemed public share for the first three months after approval, up to $300,000 in the aggregate.
After that, sponsor to deposit $0.02 per non-redeemed public share each month, up to $100,000 per month.
Sponsor intends to convert 8,433,332 Class B ordinary shares into an equal number of Class A ordinary shares upon approval.
TTM Technologies completed its prior $100 million share repurchase program, which was announced May 8, 2025, and its board authorized a new program of up to $100 million in repurchases running through October 27, 2027. The company says the buybacks were made with cash on hand and that the new program may be suspended or discontinued at its discretion.
Completed 2025 program: about 1.16 million shares repurchased on October 26 and 27, 2026, at an average price of $86.31 per share, for about $100 million in aggregate
New 2026 program authorizes repurchases of up to $100 million through October 27, 2027
Repurchases may be made through open market purchases, privately negotiated transactions or Rule 10b5-1 plans; the company is not obligated to buy any specific amount
Healthcare Triangle, Inc. completed a 1-for-20 reverse stock split effective October 26, 2026, reducing its common shares outstanding from 17,730,008 to 886,587. The company said the split is intended to meet Nasdaq's $1.00 minimum bid price requirement. Nasdaq has issued a Staff Delisting Determination, and a Nasdaq Hearings Panel hearing is scheduled for November 5, 2026, with no assurance the company will keep its listing.
1-for-20 reverse split effective 12:01 a.m. ET on October 26, 2026; shares trade split-adjusted on the Nasdaq Capital Market under HCTI
Common shares outstanding reduced from 17,730,008 to 886,587; authorized shares unchanged
Nasdaq Staff Delisting Determination received October 1, 2026; company requested a Panel hearing October 8, 2026
Hearing before the Nasdaq Hearings Panel scheduled for November 5, 2026; company states there can be no assurance of continued listing
Modine Manufacturing adopted an Executive Severance Plan on October 21, 2026, covering CFO Michael Lucareli and General Counsel Erin Roth, and approved enhanced severance and equity award changes for CEO Neil Brinker and other executives around October 21 to 27, 2026. The changes expand payouts tied to a change in control and broaden the definition of good reason, which the company says aligns its arrangements with current market standards.
Executive Severance Plan adopted October 21, 2026; Lucareli set at 1.5x regular and 2.5x change-in-control multiples, Roth at 1.0x and 2.0x
CEO Neil Brinker's offer letter amended October 22, 2026 to provide two times base salary plus target bonus on a qualifying termination outside a change in control
Performance stock awards now pay out at the greater of target or extrapolated performance upon a qualifying termination within 12 months after a change in control, without proration
Socket Mobile notified Nasdaq on October 27, 2026 that it intends to voluntarily withdraw its common stock from The Nasdaq Capital Market and move quotation to the OTCID Market under the same ticker, SCKT. The company said it was below Nasdaq's $2.5 million minimum stockholders' equity requirement and cited the costs of maintaining a Nasdaq listing; it also said operations and customer commitments will not be affected.
Written notice to Nasdaq delivered October 27, 2026 under Nasdaq Listing Rule 5840(j) and Rule 12d2-2(c)
Form 25 expected to be filed on or about November 9, 2026
Nasdaq trading expected to cease at market close on November 18, 2026; OTCID quotation expected to begin on or about November 19, 2026
Company cited Nasdaq's $2,500,000 minimum stockholders' equity requirement, which it no longer met as of an August 24, 2026 notification
Georgia Banking Company, Inc. said its common stock has been approved for direct listing on the Nasdaq Capital Market and is expected to begin trading under the ticker GBC on Thursday, October 29, 2026. The company said no new shares will be issued or sold in connection with the listing, which covers the potential resale of up to 7,074,016 shares by selling shareholders, so the listing itself does not raise new capital for the company but may add liquidity and a public trading price for existing shareholders.
Trading expected to begin Thursday, October 29, 2026, under the ticker GBC on the Nasdaq Capital Market
No new shares will be issued or sold by the company in connection with the listing
Registration Statement on Form S-1 covers potential resale of up to 7,074,016 shares by selling shareholders
As of September 30, 2026, the bank had approximately $3.1 billion in total assets
DUKE Robotics Corp. said it has canceled its 2026 Annual Meeting of Shareholders, which had been scheduled for December 15, 2026, and withdrew the proposals in its October 22, 2026 proxy statement. The company said it will provide information about any future shareholder meeting at a later date, as appropriate. The filing gives no reason for the cancellation and does not describe how the withdrawn proposals would have affected shareholders.
Annual Meeting scheduled for December 15, 2026 has been canceled
Proxy statement filed October 22, 2026 has been withdrawn from shareholder consideration
Company will provide further information on any future shareholder meeting at a later date
Envoy Medical (COCH) completed a 1-for-10 reverse stock split, effective 12:01 a.m. Eastern Time on October 26, 2026, and its shares began trading on a post-split basis on the Nasdaq Capital Market that day. The company said the split is intended to maintain compliance with Nasdaq's $1.00 minimum bid price requirement for continued listing, and that it may improve trading liquidity.
Stockholders approved the split at a special meeting on October 12, 2026; the board set the ratio at 1-for-10 on the same date, within an approved range of 1-for-5 to 1-for-25.
Every 10 issued and outstanding shares were combined into one share; fractional shares will be paid in cash.
The ticker remains COCH; the new CUSIP number is 29415V307.
The number of authorized shares and the par value per share are unchanged.
Terrestrial Energy's Board of Directors authorized a share repurchase program of up to $25 million of common stock, to be funded from existing cash on hand. The company is not obligated to buy any particular amount, and the program expires October 22, 2027. For shareholders, it is a capital allocation step that could reduce the share count, but the filing gives no timing or amount of repurchases.
Program authorizes up to $25 million of common stock repurchases
Funded from the Company's existing cash on hand
Expires October 22, 2027; can be modified, suspended or discontinued at any time
Approximately 105.9 million shares outstanding as of October 23, 2026
General Motors said its board authorized moving the listing of its common stock from the New York Stock Exchange to the Nasdaq Global Select Market, with Nasdaq having approved the listing. The stock will keep the ticker GM, and the company says no action is required from existing stockholders. The filing also amends the bylaws' independence criteria for directors, effective when Nasdaq trading begins.
NYSE listing expected to cease at the close of trading on November 16, 2026; Nasdaq trading expected to begin November 17, 2026
Common stock will continue to trade under the symbol GM
Bylaws amended to update the definition of "Independent Director," effective upon the start of Nasdaq trading
CFO Paul Jacobson said a Nasdaq listing provides eligibility for potential inclusion in the Nasdaq-100 Index
Arlo Technologies' Board of Directors approved a share repurchase program of up to $100 million of common stock, running through December 31, 2028. The company says repurchases will be made through open market purchases under Rule 10b-18, and the timing and amount will depend on market conditions. The filing does not include revenue, earnings or guidance figures, so it gives shareholders no new view of current business results.
Board authorized repurchases of up to $100 million of common stock
Program runs through December 31, 2028, unless extended or shortened by the Board
Purchases to be made through open market transactions under Rule 10b-18
CEO Matthew McRae said the board believes the shares are undervalued relative to long-term value
Onconetix, Inc. said its Board approved an additional one-for-ten reverse stock split of its common stock, which will bring the aggregate split ratio under the stockholder-approved authority to one-for-one hundred with a May 21, 2026 split. Shares are expected to begin trading on a split-adjusted basis on Nasdaq on November 6, 2026, under the existing symbol ONCO. The split reduces the share count but does not change any stockholder's percentage ownership, apart from cash paid for fractional shares.
Reverse split of one-for-ten is expected to take effect at 12:01 a.m. Eastern Time on November 6, 2026
Outstanding shares expected to fall from approximately 5.9 million to approximately 589,000
Combined with the May 21, 2026 split, the aggregate ratio is one-for-one hundred; new CUSIP 68237Q500 and symbol ONCO unchanged
No fractional shares will be issued; holders will receive cash in lieu, and authorized shares remain at 250,000,000
Rallybio's board declared an estimated $82.7 million special cash distribution, or about $13.56 per share, payable to holders of record as of November 5, 2026, in connection with its planned merger with Avenzo Therapeutics. Payment depends on stockholder approval at the November 4, 2026 annual meeting, and the actual amount may be higher or lower than the estimate. Shareholders buying during the due bill period (November 4 through November 6, 2026) will receive the distribution, while sellers will not.
Estimated cash distribution of $82.7 million, or $13.56 per share, based on 6,378,168 shares and equivalents outstanding as of October 21, 2026
Record Date November 5, 2026; ex-dividend date expected November 6, 2026; distribution scheduled for November 13, 2026
Payment conditioned on Required Company Stockholder Vote at the annual meeting at 10:00 a.m. Eastern Time on November 4, 2026
Merger closing expected on or about November 6, 2026
Northpointe Bancshares' Board approved a stock repurchase program of up to $30 million of its outstanding common stock, running from October 22, 2026 to October 22, 2027. The filing says repurchases may be made in the open market or in privately negotiated transactions, and the program can be changed or ended at any time, so shareholders would see the effect only as shares are actually bought.
Program authorizes up to $30 million of outstanding common stock repurchases
Program period runs from October 22, 2026 through October 22, 2027
Repurchases may occur in the open market or in privately negotiated deals, and may use Rule 10b5-1 plans
Chairman and CEO Chuck Williams cited confidence in the business model and strong capital position
Empery Digital resumed repurchases under its $200 million stock buyback program, buying 122,955 shares at an average of $2.89 in the week ending October 23, 2026. The company said approximately $50 million remains available under the program and it held 1,018 bitcoin, about $70 million in cash and about $35 million in debt as of that date, which shows the scale of buybacks relative to its balance sheet.
Week ending October 23, 2026: 122,955 shares repurchased at an average price of $2.89, including fees and commissions
Aggregate repurchases of 26,363,499 shares as of October 23, 2026; approximately $50 million remains under the program
As of October 23, 2026: 1,018 bitcoin, approximately $70 million in cash and approximately $35 million in debt
Midwest AI data center: partner Hunt Properties expects to execute a 15-year triple net lease in the near term; Empery Digital's investment is $65 million for a 25% interest
Between October 20 and October 23, 2026, Tessera Defense issued 5,332,617 restricted shares to Mandragola Ltd. through cashless exercises of a warrant tied to its April 2026 acquisition of a 60% interest in Dr. Frucht Systems Ltd. At a October 20, 2026 Special Meeting, stockholders approved raising the shares reserved under the 2026 Equity Incentive Plan by 5,315,000 to 6,000,000, which adds potential dilution for existing holders.
Mandragola Ltd. received 5,332,617 restricted shares in three tranches between October 20 and October 23, 2026, from exercises of the DFSL Warrant issued April 13, 2026.
Proposal 1 passed at the October 20, 2026 Special Meeting with 3,540,463 votes for, 187,380 against and 591 abstaining.
The plan reserve rose from 685,000 to 6,000,000 shares, measured after the one-for-ten reverse stock split effective September 9, 2026.
The Company reported 25,995,794 shares outstanding as of October 23, 2026, compared with 9,026,478 entitled to vote at the October 5, 2026 record date.
Myers Industries adopted an amended and restated Senior Officer Severance Plan on October 22, 2026, covering named executive officers including CEO Aaron Schapper and CFO Samantha Rutty. The changes raise cash severance terms, including adding Target Bonus to the calculation outside change-in-control periods and increasing the CEO's change-in-control multiplier from 2.5x to 3x.
Plan adopted October 22, 2026; prior plan was amended and restated effective April 26, 2023
Target Bonus added to cash severance calculation outside the Change in Control protection period
CEO change-in-control severance multiplier increased from 2.5x to 3x; new Executive Leadership Team tier set at 2x
On October 23, 2026, the SEC declared AquaBounty's Form S-3 effective, triggering the automatic conversion of all 263,753 Series A and 109,223 Series B preferred shares into 8,077,043 common shares. No preferred stock remains outstanding, and common shares outstanding rose to 13,291,953.
October 23, 2026: SEC declared the Form S-3 registration statement effective, triggering conversion
263,753 Series A and 109,223 Series B preferred shares converted into 8,077,043 common shares
Common shares outstanding totaled 13,291,953 following the conversion
Provident Financial Holdings' board authorized a new stock repurchase plan covering up to 5% of the company's common stock, about 305,477 shares, to be executed over one year. The plan starts only after the January 2026 repurchase plan, which has about 21,674 shares left to buy, is completed or expires.
Repurchase authorization covers up to 5% of common stock, approximately 305,477 shares
Plan begins after the January 2026 plan is fulfilled or expires; about 21,674 shares remain in that plan
Purchases may occur in the open market or in privately negotiated transactions over a one-year period, depending on market conditions and capital needs
Popular, Inc.'s Board of Directors approved a quarterly cash dividend of $0.90 per common share, announced October 23, 2026. The dividend is payable January 4, 2027 to shareholders of record at the close of business on November 13, 2026. The filing reports only the dividend declaration and does not include financial results.
Quarterly cash dividend of $0.90 per common share approved by the Board of Directors
Record date: close of business on November 13, 2026
Winnebago Industries entered a cooperation agreement with activist investor Vision One, under which the company will nominate Jay L. Johnson, Lamar Advertising's CFO, as an independent director at its 2026 annual meeting and add him to the Audit and Finance Committee. Vision One has withdrawn its September 15, 2026 shareholder proposals and director nominations, and the company will seek shareholder approval to phase out its classified board over three years.
Jay L. Johnson to be nominated as an independent Class III director for a term expiring at the 2029 annual meeting
Vision One withdrew its notice of shareholder proposals and director nominations dated September 15, 2026, and will cease solicitation for the 2026 annual meeting
Board to be phased from classified to annual elections, with all directors standing for election beginning at the 2029 annual meeting
2026 annual meeting is expected to be held in December
Neuphoria Therapeutics entered into Amendment No. 1 to its shareholder Rights Agreement on October 23, 2026, extending the plan's Final Expiration Date to the close of business on October 27, 2027, unless earlier extended, modified or terminated. The filing reports this as a material modification to the rights of security holders, so shareholders should note that the plan now remains in effect for an additional period.
Amendment No. 1 to the Rights Agreement dated October 23, 2026, between Neuphoria and Computershare Trust Company, N.A., as Rights Agent
Final Expiration Date extended to the close of business on October 27, 2027, unless earlier extended, modified or terminated
Original Rights Agreement dated October 27, 2025; the filing reports it as a material modification to security holder rights (Item 3.03)
Shareholders approved a change of Banzai International's legal name to Parabolic Technologies, Inc. and a reverse stock split at a special meeting on October 16, 2026. The 1-for-10 reverse split takes effect with trading on October 27, 2026, under the unchanged symbol PARA. The company says the split is primarily intended to raise the per-share price of Class A stock and maintain compliance with the Nasdaq Minimum Bid Price Requirement, though it states neither outcome is guaranteed.
Shareholders approved the Name Change Proposal with 2,266,795 votes for and 21,181 against, and the Reverse Split Proposal with 2,220,042 votes for and 67,366 against.
Based on shares outstanding on October 21, 2026, Class A shares would fall from about 5,061,208 to about 506,121 and Class B shares from 149,821 to 14,983.
Class A stock trades on a split-adjusted basis from October 27, 2026, under new CUSIP 06682J803; no fractional shares are issued and fractions are rounded up.
Advasa Holdings said its largest stockholder, Asamitsu Kosugi, intends to surrender 97,413,140 common shares to the company for no consideration, about 20% of outstanding stock. The shares would be cancelled, reducing the share count by roughly 20%, but the transaction is not complete and depends on documentation, corporate approvals and transfer agent procedures.
Mr. Kosugi, the largest stockholder, intends to surrender 97,413,140 shares for no consideration.
The shares represent approximately 20% of total outstanding common stock as of the report date.
Completion is subject to documentation, corporate approvals and transfer agent procedures; no timing was given.
Blaize's board declared a dividend of one one-thousandth of a share of Series B Preferred Stock on each outstanding common share, with a record date of October 26, 2026. The preferred carries votes only on a proposed reverse stock split and related adjournment proposals, and any shares not present or voted at the relevant meeting are automatically redeemed, so the dividend is a mechanism tied to that vote rather than a cash or income payout.
Record date for the Series B Preferred Stock dividend is October 26, 2026; the certificate of designations became effective October 21, 2026
Each Series B share carries 1,000,000 votes, so each one-thousandth share carries 1,000 votes, voting only on a reverse stock split proposal and adjournment proposals
Series B holders receive no dividends and a liquidation preference of $0.0001 per share; shares are not convertible and have no stated maturity
On October 19, 2026, shareholders approved amending the company's charter and trust agreement to let it extend its deadline to complete a business combination from October 25, 2026 to October 25, 2027, in monthly steps of up to twelve. Holders of 5,725,962 public Class A shares elected to redeem them at approximately $11.03 per share, and the filing says the sponsor must deposit funds into the trust for each extension.
Extension proposal approved with 7,721,514 votes for and 199,595 against; the company's record date was September 25, 2026.
5,725,962 public Class A shares were redeemed at approximately $11.03 per share, as of October 15, 2026.
For each one-month extension, $0.03 per remaining public share is deposited into the trust account, up to $60,000.
Sponsor ST Sponsor II Limited converted 1,464,999 Class B shares to Class A; 4,579,037 Class A shares are outstanding.
Dorchester Minerals, L.P. announced a third-quarter 2026 cash distribution of $0.882297 per common unit, covering the three months ended September 30, 2026. The filing reports cash receipts by income type for the quarter but gives no prior-period comparison, so it does not show whether results improved or declined.
Distribution of $0.882297 per common unit, payable November 12, 2026 to unitholders of record as of November 2, 2026.
Royalty Properties cash receipts of approximately $37.0 million in the third quarter; about 80% reflect oil and gas sales from May through August 2026.
Net Profits Interest receipts of approximately $3.0 million and lease bonus and other income of approximately $6.3 million.
Contributed cash attributed to the acquisition that closed on July 31, 2026 totaled approximately $4.4 million.
The Southern Company's board amended and restated its bylaws on October 20, 2026, with the changes effective immediately. The amendments tighten requirements for stockholders who ask for a special meeting or nominate directors, and they add universal proxy rule language and a Delaware forum provision, which affects how shareholders can use these rights.
Stockholders requesting a special meeting must own the required percentage of shares on a net long basis and hold them for at least one year before the request is delivered.
The advance notice window for 2027 annual meeting nominations or proposals runs from January 13, 2027 to February 12, 2027.
Exclusive forum provisions name the Delaware Court of Chancery for certain internal corporate matters and federal district courts for Securities Act of 1933 claims.
United Therapeutics' Board approved a share repurchase program of up to $2.0 billion of common stock on October 21, 2026, effective for one year through October 21, 2027. The company says the authorization gives it capacity to buy back shares, though it is not obligated to use it.
Authorization covers up to $2.0 billion of common stock, running through October 21, 2027.
Repurchases may be made through accelerated share repurchases, open market or privately negotiated transactions, or other means, and may start or stop at any time.
An existing accelerated share repurchase entered in September 2026 under the prior authorization has a scheduled termination in the fourth quarter of 2026 and will not reduce the new authorization.
Mattel entered into a cooperation agreement with EdgePoint Investment Group, described as an approximately 18% stockholder, and appointed EdgePoint Partner Lee Matheson as a director effective October 21, 2026. The Board increased its size from nine to ten members, and the filing says EdgePoint agreed to customary voting commitments and standstill restrictions. The filing does not include any financial results, so the deal's effect on shareholders depends on how the agreement is applied over time.
Lee Matheson, a Partner at EdgePoint, joined the Board effective October 21, 2026, with a term expiring at the 2027 Annual Meeting; Mattel agreed to nominate him for re-election.
The Board increased from nine to ten members in connection with the appointment.
EdgePoint agreed to customary voting commitments, standstill restrictions and confidentiality provisions.
Mattel's obligations under the agreement end in certain circumstances, including if EdgePoint ceases to beneficially own at least 10% of Mattel's outstanding common stock.
Capstone Holding Corp. (CAPS) completed a 1-for-30 reverse stock split of its common stock, effective at 12:01 a.m. Eastern time on October 19, 2026, and began trading on a split-adjusted basis on the Nasdaq Capital Market that day. The number of outstanding shares fell from about 27,536,950 to about 917,898, and the filing states the split did not change any rights or preferences of the common stock.
Ratio of 1-for-30; the Board chose this ratio from a range of 1-for-5 to 1-for-50 approved by stockholders on June 18, 2026.
Outstanding shares reduced from about 27,536,950 (as of October 8, 2026) to about 917,898.
Fractional shares will be paid in cash based on the $2.72 closing price on the effective date; new CUSIP is 14068E307.
Wealthfront's Board approved an additional $150.0 million share repurchase authorization on October 20, 2026, increasing the existing $100.0 million program approved in March 2026. The company said it expects to fund repurchases with existing cash and cash equivalents and ongoing operating cash flow, but it is not obligated to buy any set amount.
Board approved up to an additional $150.0 million in repurchases on October 20, 2026.
About $18.3 million remained under the original $100.0 million authorization as of October 20, 2026.
Repurchases may be made in the open market or in privately negotiated transactions and may be suspended or terminated at any time.
Company expects to fund repurchases with existing cash and cash equivalents and ongoing cash from operations.
CrossAmerica Partners LP's board approved a third-quarter 2026 distribution of $0.5250 per unit, annualized at $2.10 per unit and unchanged from the second quarter. Unitholders of record on November 2, 2026 will receive the payment on November 12, 2026, so the filing confirms the payout level rather than changing it.
Quarterly distribution of $0.5250 per unit attributable to Q3 2026, annualized $2.10 per unit
Consistent with the second quarter of 2026 distribution
Record date November 2, 2026; payable November 12, 2026
Third-quarter 2026 earnings to be released after market close on November 4, with a conference call on November 5 at 9:00 a.m. Eastern Time
Worthington Steel issued a statement ahead of the Kloeckner & Co SE extraordinary general meeting, scheduled for Friday, October 23, 2026, in Düsseldorf, Germany. The meeting will include a vote on implementing the Domination and Profit and Loss Transfer Agreement (DPLTA) that the two companies signed on September 8, 2026. The filing says the DPLTA takes effect only after Kloeckner shareholder approval and registration with the commercial register, so the outcome matters for shareholders of both companies.
Kloeckner & Co SE extraordinary general meeting set for Friday, October 23, 2026, in Düsseldorf, Germany
DPLTA requires at least 75% of the capital represented to pass
If the vote fails, Worthington Steel will not pursue another DPLTA vote for at least one year from the EGM date
DPLTA was entered into on September 8, 2026, and Kloeckner continues to operate independently until it becomes effective
INVE Technologies, Nasdaq-listed, started a modified Dutch auction tender offer to buy back up to $20 million of its common stock, with a price range of $2.85 to $3.40 per share. The company also gave preliminary unaudited third-quarter 2026 results, which are subject to revision and have not been audited or reviewed by its accountants.
Tender offer price range of $2.85 to $3.40 per share; the Nasdaq closing price on October 20, 2026 was $2.22 per share
Offer expires 5:00 p.m. New York City time on November 19, 2026, unless extended or terminated
Preliminary Q3 2026 revenue of $2.9 million to $3.1 million, net income of $0.4 million to $0.8 million, and net income per share of $0.01 to $0.02
Cash balance was $87.1 million as of September 30, 2026; the company expects to report final Q3 results on or about November 12, 2026
Shareholders approved an extension of Starry Sea Acquisition Corp's deadline to complete a business combination at a meeting on October 19, 2026, allowing up to twelve one-month extensions from November 7, 2026 to November 7, 2027. The company also adopted a third amended and restated charter and amended its trust agreement, which requires a monthly extension fee to be deposited into the trust account.
Shareholders voted 5,197,330 for and 1,209,656 against the charter amendment and trust agreement amendment proposals.
3,895,270 ordinary shares were tendered for redemption in connection with the vote.
The monthly extension fee is the lesser of $60,000 per month or $0.033 for each remaining public share.
The extension covers up to twelve one-month periods, ending no later than November 7, 2027.
Host Digital's board approved a stock buyback of up to $15 million of Class A common stock on October 19, 2026, running through October 19, 2027. The company does not expect to begin repurchases until it is in an open trading window, and says its top priority remains financing and delivering its contracted data center projects, including Site I in Oklahoma.
Board authorized repurchases of up to $15 million of common stock, starting October 19, 2026 and expiring October 19, 2027
Company does not expect to start repurchases until an open trading window; the program may be modified, suspended, or discontinued at any time
Site I in northeast Oklahoma has 55 MW gross power and a 15-year take-or-pay lease worth approximately $1.25 billion in base-term contracted revenue, with delivery targeted for Q1 2027
Tempest Therapeutics said its reconvened special meeting of stockholders lacked sufficient votes to approve a charter amendment that would replace specified supermajority voting requirements and permit stockholder action by written consent, so the meeting was adjourned again. The meeting will reconvene on November 12, 2026, and the proposal still requires at least 75% of the votes stockholders could cast in director elections, which matters because approval would change how shareholders can act.
Quorum was reached with 11,004,101 shares, or 74.3% of the 14,806,997 shares outstanding as of the May 28, 2026 record date, present or represented by proxy.
The proposal requires the affirmative vote of at least 75% of the votes all stockholders could cast in an annual election of directors.
The special meeting will reconvene on November 12, 2026, at 2:00 p.m. Eastern Time by live webcast.
The company has engaged Sodali & Co., a proxy solicitation firm, to help obtain sufficient votes.
On October 19, 2026, Trade Desk repriced eligible stock options under its 2025 Incentive Award Plan, reducing exercise prices above the $12.26 closing price of Class A common stock that day to $12.26. Stockholders approved the repricing at a special meeting held the same day, with 441,097,211 votes for and 232,477,009 against. The filing says the board believes the repricing restores the incentive and retention value of the options without increasing equity overhang.
Repricing took effect October 19, 2026; eligible options now carry an exercise price of $12.26.
Proposal One vote: 441,097,211 for, 232,477,009 against, 299,747 abstentions.
Excludes incentive stock options and CEO Jeff Green's market-based performance options granted in October 2021 and September 2026.
If an eligible holder's service ends (other than termination without cause) or the option is exercised before April 19, 2027, the original exercise price applies again.
AudioEye's Board approved a new program to repurchase up to $15 million of common stock, expiring October 18, 2027. The program replaces a January 2025 repurchase authorization, which the Board terminated, and will be funded with working capital and cash from operations, but the company is not committed to buying any shares.
Up to $15 million of outstanding common stock may be repurchased, expiring October 18, 2027
Replaces the January 2025 program that was scheduled to expire January 24, 2027 and was terminated
Funding will come from working capital and cash from operations; the program may be amended, suspended or discontinued at any time
CEO Kelly Georgevich said the company will report third-quarter results and fourth-quarter outlook next week
Moleculin Biotech's 1-for-20 reverse stock split takes effect at 12:01 a.m. Eastern Time on October 20, 2026, and the stock will keep the MBRX ticker under a new CUSIP. Shares outstanding will fall from approximately 20.91 million to approximately 1.05 million, and proportional adjustments will apply to outstanding options, RSUs, warrants and the equity plan reserve, while authorized shares stay at 500 million.
Effective 12:01 a.m. ET on October 20, 2026; trading on The Nasdaq Capital Market under MBRX with new CUSIP 60855D507
Shares outstanding reduced from approximately 20.91 million to approximately 1.05 million; authorized shares remain at 500 million
Stockholders approved a split ratio range of 1-for-2 to 1-for-20 at the annual meeting completed October 9, 2026; the board selected 1-for-20
Fractional shares will be paid in cash based on the average closing price over the five trading days before the split
At its October 14, 2026 annual meeting, iBio stockholders approved raising authorized common stock from 275 million to 500 million shares, effective October 16, 2026 upon filing with Delaware. They also approved an amendment to the 2023 Omnibus Incentive Plan that adds shares to the plan each year, and re-elected two Class III directors. A larger pool of authorized shares gives the company room to issue more stock, which could dilute existing holders.
Authorized common stock rose from 275,000,000 to 500,000,000 shares; Certificate of Amendment filed October 16, 2026.
Authorized share increase approved with 45,730,093 votes for and 2,052,563 against.
Plan amendment approved with 27,693,575 votes for and 8,263,100 against; plan share reserve rises each January 1 from 2027 through 2033.
Two Class III directors, William Clark and Gary Sender, were elected to terms expiring at the 2029 annual meeting.
For the week of October 12 to October 18, 2026, Strategy bought 267 bitcoin for $22.1 million, raising aggregate holdings to 848,517 bitcoin, and repurchased $193.1 million of its STRC preferred stock. The company also raised its digital credit securities repurchase authorization from $2.0 billion to $3.0 billion, with $1.16 billion remaining available as of October 18, 2026. The filing is a weekly update on capital activity and does not report earnings or guidance.
Bitcoin purchases: 267 bitcoin for $22.1 million, funded by $22.0 million of MSTR stock sale proceeds and $0.1 million of USD Cash; aggregate holdings 848,517 bitcoin
STRC repurchases: 1,938,780 shares for $193.1 million, funded from USD Cash
Repurchase authorization raised from $2.0 billion to $3.0 billion; $1.16 billion available as of October 18, 2026
USD Reserve $4.83 billion and USD Cash $447.3 million as of October 18, 2026; $45.5 million of USD Reserve used for preferred dividends
Enhanced Group Inc. (ENHA) plans a one-for-ten reverse stock split of its Class A and Class B common stock, effective 12:01 a.m. Central Time on October 29, 2026. The split reduces the number of shares outstanding tenfold while leaving each holder's percentage ownership and voting power unchanged, apart from rounding of fractional shares.
Each ten shares of each class will be combined into one share of the same class, effective October 29, 2026.
Class A shares are expected to trade split-adjusted on the NYSE under the existing symbol ENHA with new CUSIP 29333R206.
Fractional shares will be rounded up to the nearest whole share; equity awards and warrants will be adjusted proportionately.
STARRY SEA ACQUISITION CORP disclosed that the redemption deadline for its Extraordinary General Meeting expired on October 15, 2026, with 3,895,270 public shares still tendered for redemption after 601,847 requests were withdrawn. The meeting, postponed to 9:00 a.m. Eastern Time on October 19, 2026, is the point at which these redemptions would be processed, so the figure bears directly on how many public shares remain outstanding.
Redemption deadline expired at 5:00 p.m. Eastern Time on October 15, 2026.
601,847 redemption requests were withdrawn as of the deadline.
3,895,270 public shares remain tendered for redemption, including requests received between October 7 and October 15, 2026.
The meeting was postponed from October 9 to 9:00 a.m. Eastern Time on October 19, 2026, to allow more time to engage with shareholders.
SITE Centers Corp. notified the New York Stock Exchange on October 15, 2026 that it intends to voluntarily delist its common shares. The company plans to file a Form 25 on November 23, 2026, and expects the delisting to take effect before trading begins on December 4, 2026. The notice follows the sale of the company's interests in the Dividend Trust Portfolio joint venture.
Notice to NYSE provided October 15, 2026, under authority granted by the Board of Directors
Form 25 filing intended for November 23, 2026
Delisting expected to be effective before trading commences on December 4, 2026
Action follows the sale of the company's interests in the Dividend Trust Portfolio joint venture
Ellington Credit Company's board authorized a program to repurchase up to $20 million of its common shares in the open market, running until October 9, 2027. The filing says the Fund is not obligated to buy any shares and may suspend or end the program at any time.
Board authorized the Common Share Repurchase Program on October 9, 2026, for up to $20 million of common shares.
Program remains in effect until October 9, 2027, unless extended or terminated earlier.
Estimated net asset value midpoint was $4.04 per share as of September 30, 2026, per a Form 497AD filed October 16, 2026.
Oaktree Acquisition Corp. III Life Sciences moved its extraordinary general meeting, which was set for October 16, 2026, to October 23, 2026, to allow more time to solicit and collect proxy votes on a proposal to extend its deadline for completing an initial business combination. The record date of September 22, 2026 is unchanged, and previously submitted proxies remain valid.
Extraordinary general meeting moved from October 16, 2026 to October 23, 2026, at 10:00 a.m. Eastern Time
Shareholders wishing to attend in person must reserve attendance with the CEO by October 21, 2026
Record date remains September 22, 2026; existing proxies stay valid unless revoked
Redemption withdrawal requests may continue to be made until the rescheduled meeting
On October 14, 2026, FreightCar America entered a Stockholder Agreement with three OC III entities that collectively own about 48.8% of its common stock, including warrants. The company also amended and terminated its August 5, 2026 Rights Agreement, so the rights expired at the close of business that day and common holders no longer hold rights under the plan.
OC III entities collectively own about 48.8% of common stock, including warrants, per a July 2, 2026 Schedule 13D/A
Rights Agreement dated August 5, 2026 was amended to accelerate expiration from July 5, 2027 to close of business October 14, 2026
Board must review transfers of shares to any holder above 20%; agreement ends at the earlier of the fourth anniversary or when the group falls to 20% or less
Company agreed not to adopt future rights plans with an ownership trigger below 20%
IB Acquisition Corp. set December 16, 2026 as the date of its first annual stockholder meeting since its IPO, to be held virtually, and fixed October 28, 2026 as the record date for voting. The company says the meeting should help it regain compliance with a Nasdaq rule it was cited for in October 2026 after not holding an annual meeting within twelve months of its fiscal year end.
Annual Meeting set for Wednesday, December 16, 2026, at 10:00 a.m. Eastern Time, virtually via live webcast
Record date is close of business on October 28, 2026
Stockholder proposals for the proxy statement must be received by close of business on October 26, 2026
Nasdaq notified the company on October 5, 2026 that it was not in compliance with Listing Rule 5620(a)
Star Group, L.P. declared a quarterly distribution of $0.1975 per common unit for the three months ended September 30, 2026. The payout is set for unit holders of record on October 26, 2026, and will be paid November 4, 2026. The filing reports no earnings, revenue or guidance figures, so it gives shareholders the payout amount and schedule only.
Quarterly distribution of $0.1975 per common unit
Covers the three months ended September 30, 2026
Record date October 26, 2026; payment date November 4, 2026
Oaktree Acquisition Corp. III Life Sciences disclosed preliminary results of its shareholder redemption window ahead of an extension meeting. Holders tendered 13,326,977 Class A ordinary shares for redemption before the October 14, 2026 deadline. After the redemptions and a planned conversion of sponsor-held Class B shares, the company expects 11,254,791 Class A and 1,000 Class B ordinary shares to remain outstanding, which matters to shareholders because it sets the share count ahead of the proposed deadline extension.
Redemption deadline was 5:00 p.m. Eastern Time on October 14, 2026.
13,326,977 Class A ordinary shares were tendered for redemption before the deadline.
Sponsor intends to convert 4,798,758 Class B ordinary shares into Class A ordinary shares before the extension takes effect.
Shareholders meeting to vote on the extension is scheduled for October 16, 2026.
Invesco Mortgage Capital Inc. declared a $0.12 per share cash dividend for October 2026, payable November 16, 2026, and released preliminary unaudited September 30, 2026 data. Estimated book value per common share was $6.74, and the debt-to-equity ratio was 7.6x; the filing does not compare these figures with prior periods, and the data is not audited.
Monthly dividend of $0.12 per share; ex-dividend and record date October 26, 2026; payable November 16, 2026
Estimated book value per common share of $6.74 as of September 30, 2026
Total investment portfolio including TBAs of $8.0 billion; total repurchase agreement borrowings of $6.8 billion
Debt-to-equity ratio 7.6x; economic debt-to-equity ratio 8.3x; unrestricted cash and unencumbered investments of $401.3 million
At its October 12, 2026 annual meeting, All In FutureTech stockholders approved raising the share authorization under the company's 2019 Equity Incentive Plan from 627,218 to 1,911,281 shares. They also approved issuing 707,730 shares to President Yangyang Li under a May 2, 2026 agreement. The increase expands the pool of shares available for equity awards, and the Li issuance adds shares to outstanding stock.
Equity plan authorized shares rise by 1,284,063, from 627,218 to 1,911,281.
707,730 shares to be issued to President Yangyang Li under the Share Issuance and Reimbursement Agreement dated May 2, 2026.
Li share issuance vote under the NASDAQ standard: 1,570,120 for, 25,174 against, 220,610 abstentions.
All six director nominees were elected, and ZH CPA, LLC was ratified as auditor for fiscal year ending December 31, 2026.
SkinHealth Systems Inc. (SKIN) will combine every 20 shares of its Class A common stock into one share, effective at 12:00 a.m. ET on October 14, 2026, with trading on a split-adjusted basis on the Nasdaq Capital Market starting that day under the same ticker. The company said the split is intended to help it regain compliance with Nasdaq's $1.00 minimum bid price requirement, and that it does not change any stockholder's percentage ownership, except for cash paid in lieu of fractional shares.
Ratio: 1-for-20; outstanding shares expected to fall from approximately 130.3 million to approximately 6.5 million, based on shares outstanding as of October 7, 2026
Stockholders approved the split at a special meeting on September 22, 2026; the Board set the 1-for-20 ratio the same day
New CUSIP number 88331L306; ticker remains SKIN; convertible notes due 2028 conversion rate adjusted proportionately
The company states the split may not produce a sustained rise in share price, may reduce trading liquidity, and may not restore Nasdaq compliance
WhiteHorse Finance, a business development company, declared a special distribution of $0.17 per share, payable December 10, 2026 to stockholders of record as of October 30, 2026. The company also said it will release its third quarter 2026 financial results on November 9, 2026, with a conference call that day at 1:30 p.m. ET. The filing contains no financial results, so shareholders cannot yet assess performance from it.
Special distribution of $0.17 per share, payable December 10, 2026
Record date for the distribution is October 30, 2026
Third quarter 2026 results to be released Monday, November 9, 2026, with a 1:30 p.m. ET conference call
Distributions are paid from taxable earnings and may include return of capital and/or capital gains
The closed-end fund said it will start a share repurchase program that buys back shares when they trade at a discount to net asset value, and raised its regular monthly distribution to $0.1150 per share for October, November and December 2026. The fund also entered a Measurement Period that could allow its term to be continued for up to three more years if performance criteria are met, with no assurance that will happen.
Share repurchases are expected to start after an initial 30-day cooling-off period; Clear Street is the executing broker.
Monthly distribution increased to $0.1150 per share for October, November and December 2026.
Current term expires March 31, 2027, unless extended; the board may extend it for up to one year.
Distributions may be paid partly from sources other than net investment income; final tax character will be known after the fiscal year ends March 31, 2027.
Capstone Holding Corp. completed its planned move of its state of incorporation from Delaware to Nevada at 12:01 a.m. Pacific Time on October 9, 2026, by merging into a wholly owned Nevada subsidiary. Shareholders' rights are now governed by Nevada law and the new Nevada articles and bylaws, which differ in some respects from Delaware law, though the filing does not describe those differences in detail.
Each share of common and preferred stock was automatically converted one-for-one into the Nevada company's shares; no exchange of stock certificates is required.
The redomicile was approved by shareholders at the annual meeting held November 18, 2025.
The market effective date of the redomicile is October 15, 2026.
Officers and directors of the Delaware company serve as officers and directors of the Nevada company.
Sunrise Realty Trust's board authorized a stock repurchase program of up to $20.0 million through December 31, 2027. The program takes effect only after the company closes its proposed merger with Southern Realty Trust, and the company currently intends to buy at least $10.0 million of stock after closing.
Board authorized up to $20.0 million of common stock repurchases on October 12, 2026, running through December 31, 2027.
Repurchases will not begin until the Merger with Southern Realty Trust Inc. closes; no date for closing is given.
After closing, the company currently intends to repurchase at least $10.0 million as soon as practicable; the remaining $10.0 million is subject to pricing and other parameters.
The company is not obligated to buy any specific amount and may modify, suspend or end the program at any time.
Atossa Therapeutics entered into a Stapled Contingent Value Rights Agreement with VStock Transfer, LLC, and its board declared one stapled CVR for each common share outstanding at the close of business on October 19, 2026. Holders would receive a share of 25% of net proceeds from the sale or deemed monetization of the company's first qualifying FDA priority review voucher, capped at $50 million, but no voucher has been awarded and payment is not assured.
Record date is October 19, 2026; one stapled CVR per share, with shares issued later also carrying a CVR until detachment or expiration.
Aggregate CVR payments equal 25% of net proceeds from the first qualifying voucher, capped at $50 million, for vouchers awarded on or before December 31, 2036.
No priority review voucher has been awarded, and no marketing application for (Z)-endoxifen has been submitted; the company is not required to pursue approval or sell a voucher.
CVRs do not carry voting or dividend rights and will not trade separately while attached to the shares.
FS KKR Capital Corp. declared a fourth quarter 2026 regular distribution of $0.44 per share and a special distribution of $0.20 per share, both on October 7, 2026. The company also scheduled its third quarter 2026 results release and conference call for November 5, 2026, which is when shareholders will get the quarter's financial results.
Regular distribution of $0.44 per share, payable on or about December 24, 2026, to holders of record on December 16, 2026
Special distribution of $0.20 per share, payable on or about December 15, 2026, to holders of record on December 1, 2026
Third quarter 2026 results to be released before the New York Stock Exchange opens on November 5, 2026, with a 9:00 a.m. Eastern call
Virginia National Bankshares Corporation announced a share repurchase plan authorizing up to $18.7 million of its common stock through October 5, 2027. The plan gives the company flexibility to buy shares in the open market or in private transactions, but it does not require any specific amount of purchases.
Authorization: up to $18.7 million of common stock, par value $2.50 per share
Plan period: announced October 6, 2026, running through October 5, 2027
Repurchases may be made in the open market, privately negotiated transactions or otherwise, depending on market conditions and corporate needs
The company may be extended, modified, suspended or discontinued at any time at its discretion
At its October 1, 2026 annual meeting, shareholders approved a trust amendment and charter amendment that let DT Cloud Star Acquisition Corporation extend its deadline to complete a business combination from October 26, 2026 to October 26, 2027. Each one-month extension requires a deposit of $0.033 per remaining public share into the trust account. In connection with the vote, 787,135 outstanding shares were tendered for redemption.
Annual meeting held October 1, 2026; 2,766,246 shares, about 75.72% of outstanding ordinary shares, were represented, and a quorum was present.
Trust amendment allows up to twelve one-month extensions, from October 26, 2026 to October 26, 2027, at $0.033 per remaining public share per extension.
787,135 outstanding shares were tendered for redemption in connection with the shareholder vote.
Scienture Holdings, Inc. (Nasdaq: SCNX) effected a 1-for-25 reverse stock split at 12:01 a.m. Eastern Time on October 5, 2026, after its board approved the split on September 17, 2026. The company said the split is intended to help it regain compliance with Nasdaq's $1.00 minimum bid price rule. Shareholders' proportional ownership is stated to remain virtually unchanged, but the number of shares outstanding falls sharply.
Split ratio: 1-for-25, so every 25 shares became one share; the company expects about 1,642,565 shares outstanding after the split, down from 41,064,146 as of September 30, 2026.
Reason given: to regain compliance with Nasdaq's continued listing rule requiring a minimum bid price of at least $1.00 per share.
Fractional shares were not issued; holders entitled to fractions receive a cash payment in lieu.
Trading symbol remains SCNX under a new CUSIP, 80880X203 (the 8-K states 8088X203 in one place).
On October 1, 2026, Host Digital's board granted 342,864 shares of Class A common stock as restricted stock to certain employees, including CFO John Ollet, who received 74,286 shares. The company also agreed to register for resale up to 342,864 shares held by certain holders, which could add shares available for sale in the market, and the filing states the grants were made under the May 27, 2026 merger agreement with Healthy Choice Wellness II Corp. and Host Digital Infrastructure LLC.
October 1, 2026: board granted 342,864 restricted shares of Class A common stock to employees, including CFO John Ollet (74,286 shares)
Restricted shares vest in full on November 30, 2026, unless Ollet resigns voluntarily or is terminated for cause
Registration rights agreement covers resale of up to 342,864 shares; shelf registration due within 30 calendar days after September 17, 2026
Grants made pursuant to the May 27, 2026 merger agreement with Healthy Choice Wellness II Corp. and Host Digital Infrastructure LLC
Medicus Pharma Ltd. said it will consolidate its common shares on a 50-to-1 basis, effective October 12, 2026, with trading on a post-consolidation basis starting that day under the same ticker, MDCX. The company says the change is intended to raise the bid price of its shares and help it regain compliance with Nasdaq's minimum bid price requirement.
Every 50 common shares will be exchanged for one new common share, effective October 12, 2026.
Shareholders approved the consolidation, with a ratio of up to 50-to-1, at the June 3, 2026 annual meeting.
Fractional shares will be rounded down and cash paid in lieu; the new CUSIP is 58471K301 and ticker stays MDCX.
Coffee Holding Co., Inc. announced that its Board approved a share repurchase program allowing it to buy back up to $2.5 million of its common stock on the open market or in private transactions, subject to market conditions and other factors. The company intends to fund the program with available cash and future operating cash flow, and CEO Andrew Gordon said the company believes the stock price does not reflect its underlying fundamentals.
Authorized repurchases of up to $2.5 million in common stock, par value $0.001 per share
Funding from available cash and future cash flow from operations
Program may be discontinued or suspended at any time; part of repurchases may be made under a Rule 10b5-1 plan
Announced October 7, 2026 in a press release (Exhibit 99.1)
Launch Two Acquisition Corp. (LPBB) has again postponed its extraordinary general meeting, now set for Thursday, October 8, 2026, at 1:00 p.m. Eastern Time. The vote concerns an amendment that would let the company extend its deadline to complete an initial business combination in monthly steps, up to six times, from October 9, 2026 to April 9, 2027, and shareholder redemption deadlines were also pushed back to October 7, 2026.
Meeting moved from October 6, then October 7, 2026 to Thursday, October 8, 2026 at 1:00 p.m. Eastern Time.
Proposed extension would move the business combination deadline from October 9, 2026 to April 9, 2027, in up to six monthly steps.
Redemption rights deadline extended to Wednesday, October 7, 2026 at 5:00 p.m. Eastern Time.
VanEck Solana ETF (VSOL) said its sponsor declared a first quarterly cash distribution totaling $964,960, funded from net staking income. The distribution is payable October 7, 2026, to holders of record on October 6, 2026, and the trust may sell staking rewards or some SOL to fund future payments, which could affect its SOL exposure and share price.
First distribution totals $964,960 and is funded from net staking income after service provider and custodian fees
Record date is October 6, 2026; payment date is October 7, 2026; shares expected to trade ex-dividend October 6, 2026
Distribution amount depends on staking rewards received, regulatory requirements and the trust's liquidity needs, with no assurance of future amounts
Vivakor, Inc. filed a Certificate of Amendment to implement a 1-for-15 reverse stock split of its common stock, which took effect at the Nasdaq open on October 5, 2026 under the existing ticker VIVK. The company said the split is intended to increase the per-share trading price and support its continued listing on the Nasdaq Capital Market. The split follows an earlier 1-for-20 reverse split effective July 17, 2026.
Each 15 shares will be combined into one share, reducing outstanding shares from approximately 8,981,898 to approximately 598,794.
The company's new CUSIP number is 92852R700, and the ticker remains VIVK.
No fractional shares will be issued; holders who would receive a fraction will receive one whole share instead.
Stockholders approved reverse splits at the June 30, 2026 annual meeting at ratios from 1-for-2 up to 1-for-2,000 over two years.
Sonoma Pharmaceuticals entered into a new Section 382 rights agreement with Computershare on October 6, 2026, replacing its 2016 rights plan, which expires October 18, 2026. The plan is meant to guard against an ownership change that could substantially limit the company's ability to use its net operating loss carryforwards and other tax benefits, which the company says could be a substantial asset.
Rights dividend of one preferred stock purchase right per common share held on October 13, 2026 (Record Date)
Each right allows purchase of one one-thousandth of a Series B Preferred Stock share at $10.00, subject to adjustment
Rights become exercisable if a person or group acquires 4.99% or more of common stock, and expire October 6, 2036 unless earlier redeemed
Board may redeem rights at $0.0001 per right before a person becomes an Acquiring Person
At its September 30, 2026 annual meeting, VivoSim Labs stockholders elected Keith Murphy and Adam Stern as Class III directors and approved a reverse stock split, at a ratio between 1-to-5 and 1-to-20 set by the Board, that can take effect until September 30, 2027. Stockholders also approved adding 3,165,000 shares to the equity incentive plan and approved issuing shares on warrant exercises and cutting the exercise price of 2024 warrants from $9.60 to $0.85, which may affect existing holders' ownership.
Annual meeting held September 30, 2026; 6,180,635 shares, or 37.26% of 16,586,495 outstanding shares, were represented.
Reverse stock split approved at a 1-to-5 to 1-to-20 ratio, to be set by the Board on or before September 30, 2027, with 74.12% of votes cast in favor.
Equity incentive plan increase of 3,165,000 shares approved with 72.52% of votes cast in favor.
Warrant approvals cover up to 4,705,883 shares and reduce the exercise price of May 13, 2024 warrants from $9.60 to $0.85 per share.
Nexentis Technologies Inc. (NXTS) amended its outstanding warrants, effective September 29, 2026, to remove provisions that caused liability classification for accounting purposes. The company says the amended warrants qualify for equity classification, and the changes were made as part of its efforts to regain compliance with Nasdaq Listing Rule 5550(b)(1).
Amendments cover warrants tied to the L.I.A. Pure Capital Ltd. loan facility and to private placements on June 15, 2026 and June 24, 2026.
Amendments did not increase the number of shares issuable on exercise, extend warrant terms, or add economic consideration to holders.
Amendment agreements were signed September 29, 2026; the filing was dated October 6, 2026 and signed by CEO David Palach.
International Bancshares said it will voluntarily withdraw its common stock listing from Nasdaq and transfer the primary listing to the Texas Stock Exchange. Trading on Nasdaq is expected to end at the close on October 16, 2026, and begin on TXSE at market open on October 19, 2026, under the same ticker, IBOC. The company said no action is required from shareholders, and the filing contains no financial results.
Nasdaq trading expected to cease at the close on Friday, October 16, 2026
TXSE trading expected to begin at market open on Monday, October 19, 2026, under ticker IBOC
No shareholder action is required, according to the company
A closing-bell ceremony is planned in Houston on December 7, 2026
Kustom Entertainment's 1-for-10 reverse stock split and a proportional cut in authorized common shares took effect October 1, 2026, with the stock trading on a split-adjusted basis on Nasdaq. The company said the split is meant to lift its share price above the Nasdaq $1.00 minimum bid price for continued listing. At its October 5, 2026 annual meeting, stockholders approved all eleven proposals, including share issuances tied to a proposed acquisition from TFL, LLC.
Outstanding common shares fell from 6,506,860 to 650,686 after the split, subject to rounding of fractional shares; new CUSIP is 25382T705.
Authorized common shares were reduced from 13,333,333 to 1,333,334.
At the October 5, 2026 annual meeting, 3,419,508 shares were represented, about 52.55% of shares outstanding on the August 7, 2026 record date.
Stockholders approved raising authorized shares from 23,333,333 to 1,200,000,000 and issuing shares tied to the Unit Purchase Agreement dated August 31, 2026 with TFL, LLC.
Stockholders approved moving Outdoor Holding from Delaware to Texas at the September 28, 2026 annual meeting, and the conversion took effect September 30, 2026. The filing says the change did not alter the company's business, management, employees, assets or liabilities, and that stockholders do not need to exchange their shares, but certain stockholder rights did change.
Approval vote on the Texas redomestication: 74,116,057 for, 10,985,633 against, 268,587 abstentions, with 14,638,384 broker non-votes.
Effective at 10:59 p.m. Central Time on September 30, 2026; common and 8.75% Series A preferred stock converted one-for-one and continue trading on Nasdaq as POWW and POWWP.
Steven F. Urvan, Chairman and CEO, was also appointed President effective at the Effective Time; the company is moving its headquarters from Atlanta, Georgia to Dallas, Texas.
At its virtual annual meeting on October 1, 2026, Aethlon Medical's stockholders elected five directors, approved an increase of 100,000 shares to the 2020 Equity Incentive Plan, and approved a series of other proposals. The filing also shows stockholders approved raising authorized common stock from 20,000,000 to 200,000,000 shares, which could allow future share issuance and dilution for holders of the current 711,136 outstanding shares.
Five directors elected, including Chetan S. Shah, MD and Nicolas Gikakis, each for terms ending at the next annual meeting
Stockholders approved a 100,000-share increase to the 2020 Equity Incentive Plan, effective October 1, 2026
Proposal to increase authorized common shares from 20,000,000 to 200,000,000 passed with 370,879 votes for and 27,208 against
Approximately 56.21% of the 711,136 eligible shares were represented, establishing a quorum
American Outdoor Brands' Board approved a program to repurchase up to $10 million of its common stock from October 1, 2026 through September 30, 2027. The company said it has a debt-free balance sheet and that the program may be discontinued at any time.
Program authorizes up to $10 million of repurchases from October 1, 2026 to September 30, 2027.
Shares may be bought on the open market, in block trades, or in privately negotiated transactions.
The prior program, begun in 2025, had repurchased 236,907 shares at an average price of $8.15, about $1.9 million in total, as of September 30, 2026.
The company does not have to buy any particular number of shares and may end the program at its discretion.
AVAX One said it bought 333,500 of its common shares in September 2026 at an average price of $5.36, including fees and commissions, under its $40 million repurchase program. As of September 30, 2026, total repurchases since November 2025 reached 836,743 shares (adjusted for the one-for-12 reverse stock split on June 15, 2026), and about $33.9 million remains available. Interim CEO Pete Wylie said the company believes its share price is well below intrinsic value and intends to keep buying while that gap persists, though the filing states the program may be modified, suspended or discontinued at any time.
Repurchased 333,500 common shares in September 2026 at an average price of $5.36 per share, including fees and commissions
Total repurchases of 836,743 shares as of September 30, 2026, since November 2025, adjusted for the June 15, 2026 one-for-12 reverse split
About $33.9 million remains available under the $40 million program; the company is not obligated to buy any specific number of shares
Winchester Bancorp's board adopted a share repurchase program allowing the company to buy back up to 464,769 shares of common stock, or about 5% of its current outstanding shares. The program runs from September 30, 2026 to September 1, 2027, and buybacks will depend on price, regulatory requirements, and market conditions. For shareholders, a buyback of this size can reduce the number of shares outstanding, but the filing gives no commitment that the full amount will be repurchased.
Authorization covers up to 464,769 shares, about 5% of current outstanding common stock
Program commences September 30, 2026 and expires September 1, 2027
Timing and amount depend on price, regulatory considerations, market conditions, and liquidity priorities
Program may be modified, suspended, or discontinued at any time
Aterian disclosed that David E. Lazar sold his Series AA and Series AAA preferred stake to several purchasers on September 25, 2026, for an aggregate $12,000,000. After the sale Lazar holds about 3.1% of common stock, and the company says no single person or group has acquired control. The filing also reports that director Avraham Ben-Tzvi resigned and William H. Crampton joined the board, and that a $0.9936-per-CVR cash payment is due on or about October 2, 2026.
On September 25, 2026, Lazar sold all rights in 706,100 Series AA and 1,750,000 Series AAA preferred shares for $12,000,000 in aggregate, after the preferred converted into 241,861,970 common shares.
No purchaser holds more than 9.99% of fully diluted common stock, and the company says the purchasers acted independently.
William H. Crampton was appointed to the board on September 25, 2026, and to the Audit and Compensation Committees; Avraham Ben-Tzvi resigned effective September 25, 2026.
Lazar received a $150,000 retention bonus as CEO and Interim CFO, paid in two $75,000 installments; CVR holders are due approximately $0.9936 per CVR on or about October 2, 2026.
On September 29, 2026, Naoda Investments Limited transferred all ordinary shares of the sponsor, BEST SPAC I (Holdings) Corp., to A SPAC (Holdings) Group Corp., which now holds 100% of the sponsor and, through it, a stake representing approximately 80.0% of the company's outstanding ordinary shares. The filing states no changes were made to the company's directors or officers, though the sponsor's sole director changed.
Buyer A SPAC (Holdings) Group Corp. holds 100% of the sponsor, which directly holds 1,375,000 Class B ordinary shares and 277,000 Class A ordinary shares underlying private placement units.
The sponsor's stake represents approximately 80.0% of the company's issued and outstanding ordinary shares.
Yun Chen resigned as sole director of the sponsor; Claudius Tsang was appointed sole director and shares voting and investment discretion with Kam Chi Kin.
No changes were made to the directors or officers of the company itself.
Atossa Therapeutics' board approved a plan to issue one contingent value right (CVR) for each common share, giving shareholders a share of proceeds if the company monetizes its first qualifying rare pediatric disease priority review voucher. No voucher has been awarded and no product candidate has been approved, so no CVR payment is assured.
Each CVR would entitle holders to 25% of net proceeds from a qualifying voucher monetization, capped at $50 million in aggregate payments.
Shareholders of record on a record date to be announced, and shares issued later, would receive one CVR per share.
CVRs would not trade separately and would expire if no qualifying voucher is awarded by December 31, 2036, unless the Board extends that date.
Atossa has previously reported disclosed voucher sales of $100 million to $220 million over the preceding 18–24 months, but past sales do not establish the value of any voucher it might receive.
At its 2026 Annual Meeting on September 24, 2026, Korn Ferry stockholders elected all nine director nominees, approved an advisory resolution on executive pay, approved the amended and restated 2022 Stock Incentive Plan, and ratified Ernst & Young LLP as auditor for fiscal 2027. The amended plan adds 1,400,000 shares for stock-based awards and extends its term to September 24, 2036, which sets the terms under which future equity may be granted to employees and directors.
Plan adds 1,400,000 shares available for stock-based awards and extends term to September 24, 2036
Plan approved with 43,102,365 votes for and 2,155,490 against
Executive compensation advisory resolution approved with 43,800,129 votes for and 1,145,915 against
Ernst & Young LLP ratified as independent auditor for fiscal 2027 with 46,296,359 votes for
PCB Bancorp, the holding company for PCB Bank, said its Board approved on September 23, 2026 a share repurchase program for up to 700,000 shares of common stock, authorized through September 22, 2027. The filing says the company may buy shares in the open market, in block purchases, or in privately negotiated deals, and that it intends to use a Rule 10b5-1 trading plan administered by an independent broker.
Board approved the program on September 23, 2026, for up to 700,000 shares of common stock
Program is authorized through September 22, 2027 and may be modified, discontinued, or suspended at any time
Company is not obligated to buy any specific number of shares; timing and price are at its discretion
Company intends to use a Rule 10b5-1 trading plan administered by an independent broker, subject to price, volume and timing restrictions
Workhorse Group's board adopted a Value Creation Incentive Plan on September 22, 2026, and granted performance awards to CEO Scott Griffith ($15 million target) and CFO Jody Davis ($6.5 million target). Payouts depend on revenue, gross margin, operating cash flow and market capitalization milestones over a performance period from October 1, 2026 to September 30, 2031.
CEO Scott Griffith target award is $15 million; CFO Jody Davis target award is $6.5 million.
Performance period runs from October 1, 2026 to September 30, 2031.
Equity value milestone (40% of target) requires a $500 million average market capitalization over any 45-trading-day period.
Awards may be paid in cash or, at the Committee's election, in common stock.
Paramount Skydance Corporation said it will move the listing of its Class B common stock from Nasdaq to the NYSE, with Nasdaq trading ending at market close on or about October 5, 2026 and NYSE trading beginning on or about October 6, 2026. The company also set an October 5, 2026 record date for a distribution of about 470 million warrants to Class B holders, with issuance expected on or about October 13, 2026, but the distribution depends on the closing of the Warner Bros. Discovery acquisition, whose timing is not certain.
Nasdaq trading in Class B common stock expected to end at market close on or about October 5, 2026
NYSE trading expected to begin at market open on or about October 6, 2026
Record date October 5, 2026; warrants of about 470 million expected to be issued on or about October 13, 2026, one warrant per share held
Warrant exercise price set at the 20-day VWAP before the WBD Merger closing, capped at $16.02 and floored at $12.00; the distribution may be cancelled or postponed
AerSale Corporation completed the move of its legal incorporation from Delaware to Texas on September 25, 2026, after stockholders approved the change at their June 11, 2026 annual meeting. The company says its headquarters, business, management, employees and assets are unchanged, and its shares continue to trade on Nasdaq under ASLE, but stockholders' rights are now governed by Texas law and new charter documents.
Redomestication effective September 25, 2026; company continues as AerSale Corporation, a Texas corporation.
Each share of Delaware common stock automatically converted into one share of Texas common stock, par value $0.0001.
Stockholders have no appraisal or dissenters' rights; certain stockholder rights changed under the Texas charter and bylaws.
Snell & Wilmer L.L.P. legal opinion filed as Exhibit 5.1 and incorporated into three S-8 registration statements.
Genco Shipping & Trading amended its Shareholder Rights Agreement on September 25, 2026, extending the Final Expiration Date to September 30, 2027 and changing provisions on Qualifying Offers. The company says the changes follow advisory shareholder approval of an extension at its June 18, 2026 annual meeting and shareholder feedback. The amendment governs how a takeover offer can be treated under the plan, which affects shareholders' ability to receive an unsolicited bid.
Final Expiration Date extended to September 30, 2027
Minimum Qualifying Offer price measurement period shortened from 24 months to 12 months before the offer
Board consideration and special meeting periods changed from 90 Business Days to 90 calendar days
Offeror may withdraw an offer if a Material Adverse Effect has occurred and is continuing
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Frequently asked questions
Which filings get a brief?
Form 8-K filings by companies listed on a US stock exchange (NYSE, Nasdaq, Cboe; not over-the-counter stocks) that report a material event: results (Item 2.02), deals (1.01, 2.01), executive changes (5.02), restructuring (2.05), impairments (2.06), delisting notices (3.01), restatements (4.02), cybersecurity incidents (1.05), bankruptcy (1.03) and Regulation FD or other events (7.01, 8.01). Routine filings such as vote results or exhibits only are skipped.
How is the impact score set?
The AI rates each filing from 1 (routine) to 5 (major, such as a merger, bankruptcy or restatement) based only on what the filing says. It is a reading aid for sorting the day's filings, not a prediction of how the stock will move.
How quickly do briefs appear?
On weekdays the SEC filing feed is checked every 5 minutes from 6 am to 5:45 pm Eastern, when nearly all 8-Ks come in, and every hour after that until 10 pm. Briefs of the 1,000 largest companies follow within minutes; the others usually within the hour, or later the same day when many filings arrive at once.
Which companies are covered?
Every company with shares listed on the NYSE, Nasdaq or Cboe that files 8-Ks, about 4,500 of them. Foreign companies that report on Form 6-K instead are not included. The S&P 1500 only filter above narrows the list to the large, mid and small caps of the S&P Composite 1500.
Are older briefs kept?
Yes. This page shows the last 45 days, but every brief ever published stays online: each has its own page, and each company has an 8-K page listing all of its briefs, newest first, linked from its stock page and from the A-Z list of companies.